Min-Han Chi
Jung Chao
Chien-Yu Ko
Shyh-Shyun Huang- 1School of Pharmacy, China Medical University, Taichung, Taiwan
- 2Master Program for Food and Drug Safety, Chinese Medicine Research Center, Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, Taiwan
- 3Department of Food Nutrition and Health Biotechnology, Asia University, Taichung, Taiwan
Globally, approximately one-third of ischemic heart diseases are due to hyperlipidemia, which has been shown to cause various metabolic disorders. This study was aimed to disassemble and analyze hypolipidemic formulae sold by traditional Chinese medicine (TCM) pharmacies. Using commonly used statistical parameters in ethnopharmacology, we identified the core drug combination of the hypolipidemic formulae, thereby exploring the strategy by which the Taiwanese people select hypolipidemic drugs. Most important of all, we preserved the inherited knowledge of TCM. We visited 116 TCM pharmacies in Taiwan and collected 91 TCM formulae. The formulae were mainly disassembled by macroscopical identification, and the medicinal materials with a relative frequency of citation (RFC) >0.2 were defined as commonly used medicinal materials. Subsequently, we sorted the information of medicinal materials recorded in the Pharmacopeia, searched for modern pharmacological research on commonly used medicinal materials using PubMed database, and visualized data based on the statistical results. Finally, the core hypolipidemic medicinal materials used in folk medicine were obtained. Of the 91 TCM formulae collected in this study, 80 traditional Chinese medicinal materials were used, belonging to 43 families, predominantly Lamiaceae. Roots were the most commonly used part as a medicinal material. There were 17 commonly used medicinal materials. Based on medicinal records in Pharmacopeia, most flavors and properties were warm and pungent, the majority traditional effects were “tonifying and replenishing” and “blood-regulating.” Besides, the targeted diseases searching from modern pharmacological studies were diabetes mellitus and dyslipidemia. The core medicinal materials consisted of Astragalus mongholicus Bunge and Crataegus pinnatifida Bunge, and the core formulae were Bu-Yang-Huan-Wu-Tang and Xie-Fu-Zhu-Yu-Tang. In addition, 7 groups of folk misused medicinal materials were found. Although these TCMs have been used for a long period of time, their hypolipidemic mechanisms remain unclear, and further studies are needed to validate their safety and efficacy.
1 Introduction
Noncommunicable diseases (NCD), including heart diseases, strokes, cancer, and diabetes mellitus caused by hyperglycemia, and hyperlipidemia, carry common risk factors, such as tobacco smoking, alcoholism, and a sedentary lifestyle (World Health Organization, 2021a; World Health Organization, 2021b). Ischemic heart disease has been the leading cause of death globally for an extended period (World Health Organization, 2020; World Health Organization, 2021c). According to the World Health Organization (WHO) statistics, one-third of ischemic heart disease cases globally can be attributed to hyperlipidemia (World Health Organization, 2011). Many studies have shown that hyperlipidemia is a progression factor for incidence of coronary artery disease (CAD), atherosclerosis, and stroke (Yu et al., 2000; Kopin and Lowenstein, 2017). Besides, according to previous study, hyperlipidemia has a high correlation with pancreatitis, diabetes mellitus, and chronic kidney disease (CKD) (Rašlová, 2016; Hager et al., 2017; Athyros et al., 2018; Yang and McNabb-Baltar, 2020). Therefore, the American College of Cardiology (ACC) and American Heart Association (AHA) formulated treatment guidelines for lipid control, including lifestyle changes and drug treatment (Grundy et al., 2019; Reiter-Brennan et al., 2020), to prevent the occurrence of related diseases.
According to the treatment guidelines for lipid control, lifestyle changes are initially implemented for hyperlipidemia treatment, and the risk of cardiovascular diseases is continuously monitored. If the patient is at high risk for cardiovascular diseases or has familial hypercholesterolemia, drugs are included to control dyslipidemia (Grundy et al., 2019). Currently, statins are the mainstay of treatment for hyperlipidemia (Karr, 2017), where its mechanism involves the inhibition of HMG-CoA reductase to decrease blood lipid synthesis (Sirtori, 2014). Most patients use statins and are well tolerated. However, these drugs can cause side effects such as skeletal muscle pain, diabetes mellitus, and occurrence of central nervous system symptoms–statin-associated symptoms (SAS), which are commonly intolerable to patients (Thompson et al., 2016). Therefore, some patients also use other hypolipidemic agents (such as nicotinic acid, fibrates, bile acid sequestrant resin) with statins to control blood lipids effectively and reduce side effects (Karr, 2017).
According to statistics published by the Health Promotion Administration, Ministry of Health and Welfare in Taiwan, the prevalence of hyperlipidemia in people aged 18 years old and above from 2016 to 2019 was 21.63%, suggesting that every 1 out of 4–5 people suffer from hyperlipidemia (Health Promotion Administration, 2020). Nowadays, public acceptance of traditional Chinese medicine (TCM) has gradually increased (Sham et al., 2014; Hu and Wang, 2019). Although most people still comply with the treatment guidelines for dyslipidemia and use western medicine for lipid control, few people cannot tolerate the side effects of western medicine so that they change to use TCM combined with dietary control to treat dyslipidemia (Sham et al., 2014).
According to the theory of Chinese medicine, when “phlegm” and “dampness,” which are pathological products due to improper diet, generate in the body, if they are not handled properly, they will turn the body constitution into “qi stasis and blood stagnation” state, leading to abnormal blood circulation. If the situation continues, it will cause the weakness of liver, spleen and kidney. What’s worse, under the circumstances, “phlegm” and “dampness” are more likely to be generated, and such vicious circle will lead to the onset of hyperlipidemia (Shi and Li, 2007; O'Brien, 2010). In order to effectively eliminate “phlegm” and “dampness”, Chinese medical physician often use dampness-draining diuretic medicinal (e.g., Nelumbinis folium and Alismatis rhizoma) and blood-activating and stasis-dispelling medicinal (e.g., Persicae semen and Carthami flos) to improve body constitution so as to treat hyperlipidemia.
In addition to selecting TCM for regulating blood lipid level according to the theory of Chinese medicine, numerous modern pharmacological studies have shown that many TCMs exhibit hypolipidemic activity, such as Salviae miltiorrhizae radix et rhizoma, Crataegi fructus, Carthami flos, and Astragali radix (Guo et al., 2014; Liu J. et al., 2018; Fan et al., 2018). In addition, recent drug development has involved with extracting critical components from natural products, and western medicine formulations, such as capsules and pills, are used to improve the convenience of taking medicine and patient compliance. Well-known examples include extracting the active ingredient from Monascus purpureus Went., which was used to prepare a Chinese medicine capsule as a lipid-lowering agent; its main active ingredient is monacolin K (lovastatin), which is a statin drug. Although studies have shown its hypolipidemic effects, it can still cause severe side effects such as rhabdomyolysis (Lee et al., 2013). Therefore, modern research has focused on exploring other compounds in red yeast rice extract, such as monascin and ankaflavin (Lee et al., 2013; Lin et al., 2017; Xiong et al., 2019). In addition, studies have shown that monascin and ankaflavin have better hypolipidemic effects and lower toxicity compared with monacolin K (Lin et al., 2017).
Taiwanese people mainly obtain Chinese herbal medicines from health facilities (prescription Chinese herbal medicines) and TCM pharmacies (non-prescription Chinese herbal medicines). A study calculated the prevalence of Chinese herbal medicines purchased by Taiwanese people within 1 year and found that 74.8% of the public purchased non-prescription Chinese herbal medicines (Hu et al., 2020). With regards to this, TCM pharmacies seem to be the main suppliers for patients in Taiwan. However, types and dose ratios of medicinal materials, which are sold by different TCM pharmacies, differ. Recent studies analyzing hypolipidemic TCMs in Taiwan only used the National Health Insurance Research Database (NHIRD) to compile medication profiles (Chu et al., 2015) and did not examine the hypolipidemic formulae used by TCM pharmacies. In addition, a survey data from the Department of Statistics, Ministry of Health and Welfare revealed that the mean age of Chinese medicine distributors was 60 years, suggesting that the number of pharmacies and inherited knowledge related to TCM is gradually decreasing. Therefore, recording and preserving this crucial knowledge is necessary. The objective of this study was to use a systematic analysis to disassemble and analyze hypolipidemic formulae sold by TCM pharmacies and identify the core drug combination of hypolipidemic formulae, thereby exploring strategies by which the Taiwanese people select hypolipidemic drugs. Most importantly, we preserved the inherited traditional folk Chinese medicine knowledge.
2 Materials and Methods
2.1 Ethics Review
The study period was conducted from August 2020 to August 2021, and was approved by the Central Regional Research Ethics Committee of China Medical University, Taichung, Taiwan (CRREC-109-125) (Supplementary Figure S1).
2.2 Study Procedure
This study was divided into four stages: preparation of fieldwork, fieldwork, identification and preservation of medicinal materials, and analysis and sorting of medicinal material information. The detailed steps are shown in the flowchart (Supplementary Figure S2).
2.2.1 Preparation of Fieldwork
Taiwan is a spindle-shaped island located in the west Pacific Ocean; its latitude range is 21°54′N–25°17′N, longitude range is 120°04′E–122°00′E, and the area is 35,873.196 km2. In this study, the statistical results of drug administration published by the Ministry of Health and Welfare (Ministry of Health and Welfare, 2021) were used to calculate the distribution ratios of TCM pharmacies in counties and cities of Taiwan. Set an anticipated number of formulae collected from each country and city. Finally, Google Maps was used to search and label the TCM pharmacies for the purpose of visit.
2.2.2 Fieldwork
Visits were made to the labeled TCM pharmacies, hypolipidemic TCM formulae were purchased, and purchase information was recorded. If the formula purchase failed, the reason for failure was documented, and other local TCM pharmacies were visited immediately until all the expected number of formulae were collected. After the completion of this procedure, the formulae were disassembled in the lab.
2.2.3 Identification and Preservation of Medicinal Materials
After the formula disassembly was completed, macroscopical identification was used to confirm the medicinal materials. The origin of each medicinal material was confirmed by Dr. Shyh-Shyun Huang (Associate professor of the School of Pharmacy, China Medical University, Taichung, Taiwan) and Dr. Jung Chao (Assistant Professor of the Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, Taiwan). After the medicinal materials were identified, they were photographed, numbered, and stored in the Dr. Shyh-Shyun Huang’s laboratory in China Medical University, Taichung, Taiwan.
2.2.4 Analysis and Sorting of Medicinal Material Information
After identification of medicinal materials, the records of all collected medicinal materials obtained from various pharmacopeias were tallied. The pharmacopeias included Taiwan Herbal Pharmacopoeia 4th Edition (Taiwan Herbal Pharmacopeia 4th Edition Committee, 2021), Pharmacopoeia of the People’s Republic of China 2020 Edition (Chinese Pharmacopoeia Commission, 2020), and Chinese Materia Medica (National Administration of Traditional Chinese Medicine “Chinese Materia Medica” Editorial Board, 1999). The material information was then sorted in terms of kingdom, local name, Latin name, scientific name, family, part used, traditional use, and flavors and properties. However, the literature used as a reference for data search and sorting in this study were pharmacy papers and their codification were not based on plant taxonomy. In order to facilitate subsequent data collection, the content in World Flora Online (Royal Botanic Gardens and Garden, 2021) was used as a standard, and the scientific name and family of medicinal materials were corrected.
Following this, we corrected misused items in all collected medicinal materials, and the ratios of authentic and misused items were calculated. In addition, the relative frequency of citation (RFC) of all collected medicinal materials was calculated using the following equation (Ahmad et al., 2017):
After referring to ethnopharmacology literature, medicinal materials with an RFC >0.2 were deemed to be commonly used medicinal materials (Chao et al., 2020; Ko et al., 2021; Su et al., 2021). Following this, the PubMed database was used to search for modern pharmacological research on these commonly used medicinal materials by using [(the scientific names of medicinal materials) and (Metabolic Diseases)] as keywords. The search period was from 2017 to 2021. If no relevant pieces of literature were found, a search was performed without date constraints.
According to the statistical variable classification, the appearance of medicinal materials was a categorical variable. For examining the correlation between the medicinal materials, their usage in each TCM pharmacy was used as a binary variable, and a 2 × 2 contingency table was constructed based on the number of occurrences of any two medicinal materials. The tabulated data were used to calculate the Phi correlation coefficient–a statistical parameter for measuring the correlation between binary variables. In this study, R software (version 4.1.1) was used to calculate Phi correlation coefficient. The range of the Phi correlation coefficient was between -1 and +1, suggesting that the closer the value is to the poles, the higher the correlation (positive or negative correlation). Finally, GraphPad Prism software (version 9.1.1) and Adobe illustrator (version 23.0.5) were used to make heat map and cladogram which were based on Phi correlation coefficient and RFC. The grid color in the heat map was based on the Phi correlation coefficient of two medicinal materials. The redder the color, the higher the correlation between the two medicinal materials. On the contrary, the bluer the color, the lower the correlation between the two medicinal materials. Through data visualization, the core medicinal materials were found out, and the composition of the hypolipidemic formulae commonly used by the public was concluded.
3 Results
3.1 Results of Hypolipidemic Formulae Collection and Analysis of Medicinal Material Information
According to data published by the Department of Statistics, Ministry of Health and Welfare in 2021, there were 9671 TCM pharmacies in Taiwan by the end of 2020, of which most were in Kaohsiung (n = 1,524, 15.65%) and the least in Taitung (n = 54, 0.56%) (Ministry of Health and Welfare, 2021). In this study, fieldwork was performed from August 2020 to August 2021, 116 TCM pharmacies were visited, of which most were in Kaohsiung (n = 15) and the least in Keelung (n = 1), Hualien (n = 1) and Taitung (n = 1). Finally, 91 hypolipidemic formulae were collected (Figure 1). In Figure 1, the distribution of red dots represents the location of pharmacies, and the greener the color of each city area, the more the number of pharmacies visited in the city.
FIGURE 1. Distribution map of 91 hypolipidemic formulae.
Statistical analysis of the disassembly results revealed that 80 TCM materials were collected in this study, of which 77 were plants (96.25%), two were fungi (2.5%), and one was an animal (1.25%) (Figure 2A). All collected medicinal materials were divided into 43 families, most of which were from Lamiaceae (frequency = 8), followed by Fabaceae (frequency = 7) (Figure 2B). Statistical results of the parts used suggested that roots (frequency = 20) were the most commonly used, followed by rhizomes (frequency = 10) (Figure 2C).
FIGURE 2. Classification of 80 TCM materials from 91 hypolipidemic formulae (A) kingdom (B) family (C) part used. Note: Parts with a frequency = 1 in the bar chart were combined in Others.
3.2 Statistics of Core Medicinal Materials
The Phi correlation coefficients of the 17 commonly used medicinal materials were analyzed, of which one positive correlation group consisted of Astragalus mongholicus Bunge, Angelica sinensis (Oliv.) Diels, Ligusticum striatum DC., Cyathula officinalis K. C. Kuan, Amynthas aspergillum (E. Perrier), Paeonia lactiflora Pall., Chaenomeles speciosa (Sweet) Nakai, Prunus persica (L.) Batsch, Dipsacus inermis Wall., Carthamus tinctorius L., Cynomorium coccineum subsp. songaricum (Rupr.) J. Léonard, and Gastrodia elata Blume (known as the Astragali radix group). Another positive correlation group comprised Crataegus pinnatifida Bunge, Senna obtusifolia (L.) H. S. Irwin & Barneby, Glycyrrhiza uralensis Fisch., Citrus reticulata Blanco, and Salvia miltiorrhiza Bunge (known as Crataegi fructus group) (Figure 3A).
FIGURE 3. Correlation of 17 commonly used medicinal materials (A) Heat map (B) Cladogram. ATG, Astragalus mongholicus Bunge; AEM, Amynthas aspergillum (E. Perrier); AGS, Angelica sinensis (Oliv.) Diels; CML, Chaenomeles speciosa (Sweet) Nakai; CMR, Cynomorium coccineum subsp. songaricum (Rupr.) J.Léonard; CNX, Ligusticum striatum DC.; CRP, Citrus reticulata Blanco; CSA, Senna obtusifolia (L.) H. S. Irwin & Barneby; CTG, Crataegus pinnatifida Bunge; CTL, Cyathula officinalis K. C. Kuan; CTM, Carthamus tinctorius L.; DSC, Dipsacus inermis Wall.; GRZ, Glycyrrhiza uralensis Fisch.; GTD, Gastrodia elata Blume; PNR, Paeonia lactiflora Pall.; PSC, Prunus persica (L.) Batsch; SVM, Salvia miltiorrhiza Bunge.
The Phi correlation coefficients of the Astragali radix group (compared with Astragalus mongholicus Bunge) listed in the descending order were Astragalus mongholicus Bunge (correlation coefficient = 1.000), Cyathula officinalis K. C. Kuan (correlation coefficient = 0.6851), Chaenomeles speciosa (Sweet) Nakai (correlation coefficient = 0.6540), Dipsacus inermis Wall. (correlation coefficient = 0.6540), Amynthas aspergillum (E. Perrier) (correlation coefficient = 0.6395), Ligusticum striatum DC. (correlation coefficient = 0.6152), Prunus persica (L.) Batsch (correlation coefficient = 0.6079), Angelica sinensis (Oliv.) Diels (correlation coefficient = 0.6051), Paeonia lactiflora Pall. (correlation coefficient = 0.5939), Gastrodia elata Blume (correlation coefficient = 0.5938), Cynomorium coccineum subsp. songaricum (Rupr.) J. Léonard (correlation coefficient = 0.5616), and Carthamus tinctorius L. (correlation coefficient = 0.4997). The Phi correlation coefficients of the Crataegi fructus group listed in the descending order (compared with Crataegus pinnatifida Bunge) were Crataegus pinnatifida Bunge (correlation coefficient = 1.000), Senna obtusifolia (L.) H. S. Irwin & Barneby (correlation coefficient = 0.6318), Citrus reticulata Blanco (correlation coefficient = 0.4615), Salvia miltiorrhiza Bunge (correlation coefficient = 0.3923), and Glycyrrhiza uralensis Fisch. (correlation coefficient = 0.2298). In addition, the Phi correlation coefficients of tonifying and replenishing medicinal and blood-regulating medicinal were the highest in the Astragali radix group; the Phi correlation coefficients of disgestant medicinal and heat-clearing medicinal were the highest in the Crataegi fructus group (Figure 3B).
3.3 Sorting of Traditional Effects and Modern Pharmacological Research on Commonly Used Medicinal Materials
According to the literature, medicinal materials with RFC >0.2 are defined as commonly used materials (Chao et al., 2020; Ko et al., 2021; Su et al., 2021). In this study, a total of 17 of such materials have been investigated, which are ranked based on RFC in descending order: Astragalus mongholicus Bunge (RFC = 0.582), Crataegus pinnatifida Bunge (RFC = 0.516), Angelica sinensis (Oliv.) Diels (RFC = 0.462), Ligusticum striatum DC. (RFC = 0.440), Cyathula officinalis K. C. Kuan (RFC = 0.396), Amynthas aspergillum (E. Perrier) (RFC = 0.396), Paeonia lactiflora Pall. (RFC = 0.396), Chaenomeles speciosa (Sweet) Nakai (RFC = 0.374), Prunus persica (L.) Batsch (RFC = 0.374), Dipsacus inermis Wall. (RFC = 0.374), Carthamus tinctorius L. (RFC = 0.363), Cynomorium coccineum subsp. songaricum (Rupr.) J.Léonard (RFC = 0.341), Gastrodia elata Blume (RFC = 0.330), Senna obtusifolia (L.) H. S. Irwin & Barneby (RFC = 0.330), Glycyrrhiza uralensis Fisch. (RFC = 0.264), Citrus reticulata Blanco (RFC = 0.253), and Salvia miltiorrhiza Bunge (RFC = 0.242) (Table 1).
TABLE 1. Commonly used medicinal materials with RFC >0.2.
With regards to property and flavor, the most common property of the 17 commonly used medicinal materials was warm (frequency = 9), followed by plain (frequency = 4), and the most common flavor was sweet (frequency = 8), followed by bitter (frequency = 7) (Figures 4A,B). Combining the two factors, i.e., properties and flavors, most drugs were warm and pungent (frequency = 5), followed by sweet and warm (frequency = 4) (Figure 4C).
FIGURE 4. Flavor and property statistics and analysis charts of 17 commonly used medicinal materials (A) Property radar plot (B) Flavor radar plot (C) Correlation heat map of flavors and properties.
The 17 commonly used medicinal materials can be divided into seven categories based on their traditional use, namely tonifying and replenishing medicinal (frequency = 5), blood-regulating medicinal (frequency = 5), liver-pacifying and wind-extinguishing medicinal (frequency = 2), heat-clearing medicinal (frequency = 2), disgestant medicinal (frequency = 1), dampness-dispelling medicinal (frequency = 1), and qi-regulating medicinal (frequency = 1). Among these categories, tonifying and replenishing medicinal can be subdivided into yang-tonifying medicinal (frequency = 2), qi-tonifying (frequency = 2), and blood-tonifying medicinal (frequency = 1); heat-clearing medicinal can be subdivided into heat-clearing and blood-cooling medicinal (frequency = 1) and heat-clearing and fire-purging medicinal (frequency = 1) (Figure 5A).
FIGURE 5. Purpose statistics of 17 commonly used medicinal materials (A) Traditional use statistics (B) Modern pharmacological research statistics.
With regard to modern pharmacological research, search results from PubMed database showed that the therapeutic purpose of 17 commonly used medicinal materials was distributed in 11 diseases or physiological responses, which in descending order were diabetes mellitus (13.59%), dyslipidemia (12.62%), anti-inflammation (12.62%), anti-oxidation (11.65%), obesity (8.74%), cardiovascular disease (8.74%), osteoporosis (7.77%), hepatic injury (7.77%), anti-cancer (6.80%), hypertension (5.83%), and renal injury (3.88%) (Figure 5B).
3.4 Statistics of Authentic and Misused Medicinal Materials
Of the 91 hypolipidemic formulae collected in this study, there were seven groups of authentic and misused medicinal materials (Table 2; Figure 6):
1. Drynaria roosii Nakaike (Authentic, 0%) and Araiostegia divaricata (Blume) M. Kato (Misused, 100%)
2. Rosa rugosa Thunb. (Authentic, 20%) and Rosa chinensis Jacq. (Misused, 80%)
3. Artemisia scoparia Waldst. & Kitam. (Authentic, 0%), Origanum vulgare L. (Misused, 100%)
4. Cyathula officinalis K. C. Kuan (Authentic, 6.82%), Strobilanthes forrestii Diels (Misused, 75%), and Achyranthes bidentata Blume (Misused, 18.18%)
5. Astragalus mongholicus Bunge (Authentic, 1.85%) and Hedysarum polybotrys Hand.-Mazz. (Misused, 98.15%)
6. Senna obtusifolia (L.) H. S. Irwin & Barneby (Authentic, 93.33%), Senna occidentalis (L.) Link (Misused, 6.67%)
7. Reynoutria multiflora (Thunb.) Moldenke (Authentic, 23.08%) and Reynoutria ciliinervis (Nakai) Moldenke (Misused, 76.92%)
TABLE 2. Analysis of authentic and misused medicinal materials
FIGURE 6. Photograph of authentic and misused medicinal materials.
4 Discussion
4.1 Analysis of the Corresponding Prescriptions of Core Medicinal Materials
In this study, the core hypolipidemic formulae could be classified into two medicinal material combinations: The first comprising 12 medicinal materials in which Astragalus mongholicus Bunge was the dominant and contained Astragalus mongholicus Bunge, Cyathula officinalis K. C. Kuan, Chaenomeles speciosa (Sweet) Nakai, Dipsacus inermis Wall., Amynthas aspergillum (E. Perrier), Ligusticum striatum DC., Prunus persica (L.) Batsch, Angelica sinensis (Oliv.) Diels, Paeonia lactiflora Pall., Gastrodia elata Blume, Cynomorium coccineum subsp. songaricum (Rupr.) J. Léonard, and Carthamus tinctorius L. These formulae included Bu-Yang-Huan-Wu-Tang [Astragalus mongholicus Bunge, Angelica sinensis (Oliv.) Diels, Paeonia lactiflora Pall., Amynthas aspergillum (E. Perrier), Ligusticum striatum DC., Prunus persica (L.) Batsch, Carthamus tinctorius L.] (Zheng XW. et al., 2018), and Xie-Fu-Zhu-Yu-Tang [Angelica sinensis (Oliv.) Diels, Rehmannia glutinosa (Gaertn.) DC., Prunus persica (L.) Batsch, Carthamus tinctorius L., Citrus × aurantium L., Paeonia lactiflora Pall., Bupleurum chinense DC., Glycyrrhiza uralensis Fisch., Platycodon grandiflorus (Jacq.) A. DC., Ligusticum striatum DC., and Achyranthes bidentata Blume] (Wang and Qiu, 2019). The second combination contained five medicinal materials in which Crataegus pinnatifida Bunge was the dominant, and comprised of Crataegus pinnatifida Bunge, Senna obtusifolia (L.) H. S. Irwin & Barneby, Citrus reticulata Blanco, Salvia miltiorrhiza Bunge, and Glycyrrhiza uralensis Fisch. Based on previous studies, this combination of medicinal materials is often used in hypolipidemic control (Yin and He, 2015).
4.2 Correlation Analysis of Core Medicinal Materials
To further confirm the traditional use distribution and composition of hypolipidemic formulae, two medicinal materials, Astragalus mongholicus Bunge and Crataegus pinnatifida Bunge with high RFC and negative correlation with each other, were used to construct cladograms based on Phi correlation coefficients. The size of the circles represents the magnitude of the RFC value, and different colors represent different traditional uses. From the cladograms, it can be seen that medicinal materials with higher RFC may not necessarily have higher correlation coefficients. In addition, Phi correlation coefficient analysis show that Chaenomeles speciosa (Sweet) Nakai and Dipsacus inermis Wall have the same correlation coefficient, showing that these two drugs are a pair that will simultaneously occur in hypolipidemic formulae.
4.3 Modern Research on the Flavor and Property of Core Medicinal Materials
Each medicinal material might incorporate many flavors and only one property. The properties can be classified as cold, cool, plain, warm, and hot, of which cool and cold are in one group, and warm and hot are in another. The two concepts are similar within a group and differ only in magnitude; besides, the plain property lies between cool and warm (LIU et al., 2012; Liu et al., 2020). Flavors can be classified as sour, bitter, sweet, pungent, salty, plain, and astringent. Originally, the flavors referred to the taste of the medicine; however, subsequently, flavors and properties were combined to analyze the effects of the drugs (Zhang and Liu, 2015). This study showed that hypolipidemic medicinal materials were predominantly “warm and pungent” and “sweet and warm.” According to previous studies, the primary active ingredients of pungent medicinal materials are volatile oils, terpenoids, and alkaloids (Zhang and Liu, 2015), and the top three active targets with the highest correlation with pungent medicinal materials were nuclear factor erythroid 2-related factor 2 (NFE2L2), androgen receptor (AR), and prostaglandin G/H synthase 2 (PTGS2) (Chen Z. et al., 2019a). NFE2L2 is associated with atherosclerosis (Figarska et al., 2014), AR is associated with coronary artery disease (Agiannitopoulos et al., 2016), and PTGS2 is associated with myocardial infarction (Patrono, 2016). Pungent medicinal materials mainly act on the aforementioned targets and help treat cardiovascular diseases. The active ingredients of sweet medicinal materials are carbohydrate, amino acids, and vitamins (Zhang and Liu, 2015), possessing tonifying and replenishing effects (Zhang J. Y. et al., 2016). Tonifying and replenishing properties of medicinal materials can decrease blood viscosity and help in the treatment of acute cerebral infarction (Zhou D. et al., 2020). In addition, these can regulate neurotransmitters, such as serotonin and norepinephrine, to treat central nervous system diseases (Zhang X. et al., 2018). Warm and hot medicinal materials tend to promote norepinephrine release (Liu et al., 2008; Wang et al., 2014), which can increase blood flow in the coronary arteries, kidneys, brain, and myocardium (Hoekstra et al., 1990; Di Giantomasso et al., 2002) and reduce cardiovascular ischemia. According to TCM theory, pungent medicinal materials can promote blood circulation, resolve stasis, and relieving exterior syndrome by dispel heat; sweet medicinal materials can tonify qi and blood, and regulate the property of TCM in formulae. Overall, the medicinal materials with sweet and pungent flavors and warm property can promote blood circulation and help irradiate blood stasis, regulate menstruation, soothe pain (Sun et al., 2015; Zhang and Liu, 2015; Zhang J. Y. et al., 2016), and also enhance blood circulation to prevent vascular occlusion, which is consistent with the findings of modern research.
4.4 Analysis of Authentic and Misused Medicinal Materials
The official literature for TCM materials in Taiwan is the Taiwan Herbal Pharmacopeia, and medicinal materials recorded in the pharmacopeia and used according to TCM theory are defined as authentic drugs. During formula disassembly and literature sorting, we found that many medicinal materials collected in this study did not appear in existing pharmacopeias or used according to TCM theory and are considered to be misused medicinal materials. Further analysis of the ratio of authentic and misused medicinal materials found that the ratio of misused medicinal materials is high, showing a frequent medicinal material misuse by the Taiwanese public. Therefore, more TCM course training is required to improve the TCM identification capabilities of TCM suppliers and the public to prevent inferior medicinal materials from driving out superior medicinal materials.
4.5 Usage of Hypolipidemic Formulae in Taiwan
Previous studies on hypolipidemic TCM usage by Taiwanese people have collected data from the NHIRD for statistical analysis, and the hypolipidemic formulae prescribed by TCM physicians in Taiwan are mainly Xie-Fu-Zhu-Yu-Tang and Jia-Wei-Xiao-Yao-San, and hypolipidemic medicinal materials are mainly Crataegus pinnatifida Bunge and Salvia miltiorrhiza Bunge (Chu et al., 2015). As mentioned above, the trend of core hypolipidemic formulae usage found in this study was nearly identical to that of the previous study, and the difference between TCM prescription and traditional hypolipidemic formulae was that the latter additionally contained medicinal materials in Bu-Yang-Huan-Wu-Tang.
4.6 Study on the Hepatotoxicity of Commonly Used Medicinal Materials for Hyperlipidemia
Chinese herbal medicine is frequently used international. According to statistics from the National Center for Complementary and Integrative Health, one in five Americans used Chinese herbal medicine (National Center for Complementary and Integrative Health, 2019). However, the use of Chinese herbal medicine is mostly empirical and without safety assessment, which is the most important part in the process of western drugs development. In addition, people pay more and more attention to adverse drug reactions. Therefore, herb-induced liver injury (HILI) is gradually discussed in current researches. Referring to the previous meta-analysis study (Byeon et al., 2019), among the 17 commonly used medicinal materials in this study, there was only Cassiae semen reported to induce HILI, and the other 16 medicinal materials have not been reported to induce hepatotoxicity. In conclusion, most of commonly used medicinal materials in this study are safe.
4.7 Limitation
There are some limitations to this study—with regard to the selection of TCM pharmacies, although the pharmacies we visited have high local traffic and are highly representative, the distribution of these pharmacies in various counties and cities is not uniform, and most are located in the city center and easily accessible sites. Therefore, there was a slight sampling bias in this study. In future studies, the number of pharmacies sampled will be increased to evaluate hypolipidemic TCM usage more accurately in public. Considering medicinal material identification, TCM may have many origins. However, only macroscopic identification was employed in this study, and we could not determine the origins of the medicinal materials collected. In the future, a chemical identification procedure will be employed to determine the components of medicinal materials and clarify their exact origin, and the proportion of multi-origin medicinal materials used will also be discussed.
5 Conclusion
This study is the first ethnobotanical study that sorted and analyzed traditional hypolipidemic formulae in Taiwan. The results of this study showed that the traditional hypolipidemic formulae were similar to the fixed TCM formulae: Bu-Yang-Huan-Wu-Tang and Xie-Fu-Zhu-Yu-Tang. Besides, we recorded inherited TCM knowledge regarding hypolipidemia in Taiwan through this investigation. Although these TCMs have been used for a long time, their hypolipidemic mechanisms still remain unclear, and more studies are needed to validate their safety and efficacy.
Data Availability Statement
The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.
Ethics Statement
The studies involving human participants were reviewed and approved by Central Regional Research Ethics Committee of China Medical University, Taichung, Taiwan. Written informed consent for participation was not required for this study in accordance with the national legislation and the institutional requirements.
Author Contributions
M-HC, JC, C-YK, and S-SH performed the field investigation and organized and analyzed the database. M-HC, JC, C-YK, and S-SH contributed conception and design of the study. S-SH and JC identified the botanical materials. M-HC and C-YK drafted the manuscript. All authors contributed to manuscript revision, read, and approved the submitted version. S-SH provided guidance for the project and supervised the experiment and manuscript review.
Funding
This research was funded by the Tsuzuki Institute for Traditional Medicine, Grant numbers 108727B8, 109727B8 and 110727B8; China Medical University, Grant numbers CMU109-MF-95; the Ministry of Science and Technology, Grant number MOST 107-2320-B-039-030-MY3 and 109-2813-C-039-061-B.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Acknowledgments
The authors would like to thank the 62nd and 63rd pharmacy students of China Medical University for their assistance in this study.
Supplementary Material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fphar.2022.900693/full#supplementary-material
Abbreviations
ACC, American College of Cardiology; AEM, Amynthas aspergillum (E.Perrier); AGS, Angelica sinensis (Oliv.) Diels; AHA, American Heart Association; AR, androgen receptor; ATG, Astragalus mongholicus Bunge; CAD, coronary artery disease; CKD, chronic kidney disease; CML, Chaenomeles speciosa (Sweet) Nakai; CMR, Cynomorium coccineum subsp. songaricum (Rupr.) J.Léonard; CNX, Ligusticum striatum DC.; CRP, Citrus reticulata Blanco; CSA, Senna obtusifolia (L.) H.S.Irwin and Barneby; CTG, Crataegus pinnatifida Bunge; CTL, Cyathula officinalis K.C.Kuan; CTM, Carthamus tinctorius L.; DSC, Dipsacus inermis Wall.; GRZ, Glycyrrhiza uralensis Fisch.; GTD, Gastrodia elata Blume; HILI, herb-induced liver injury; NCD, noncommunicable diseases; NFE2L2, nuclear factor erythroid 2-related factor 2; NHIRD, National Health Insurance Research Database; PNR, Paeonia lactiflora Pall.; PSC, Prunus persica (L.) Batsch; PTGS2, prostaglandin G/H synthase 2; RFC, relative frequency of citation; SAS, statin-associated symptoms; SVM, Salvia miltiorrhiza Bunge; TCM, traditional Chinese medicine; WHO, World Health Organization.
References
Abd Rashed, A., and Rathi, D. G. (2021). Bioactive Components of Salvia and Their Potential Antidiabetic Properties: A Review. Molecules 26 (10), 3042. doi:10.3390/molecules26103042
Agiannitopoulos, K., Bakalgianni, A., Marouli, E., Zormpa, I., Manginas, A., Papamenzelopoulos, S., et al. (2016). Gender Specificity of a Genetic Variant of Androgen Receptor and Risk of Coronary Artery Disease. J. Clin. Lab. Anal. 30 (3), 204–207. doi:10.1002/jcla.21837
Ahmad, K. S., Hamid, A., Nawaz, F., Hameed, M., Ahmad, F., Deng, J., et al. (2017). Ethnopharmacological Studies of Indigenous Plants in Kel Village, Neelum Valley, Azad Kashmir, Pakistan. J. Ethnobiol. Ethnomed. 13 (1), 68. doi:10.1186/s13002-017-0196-1
Aierken, A., Buchholz, T., Chen, C., Zhang, X., and Melzig, M. F. (2017). Hypoglycemic Effect of Hawthorn in Type II Diabetes Mellitus Rat Model. J. Sci. Food Agric. 97 (13), 4557–4561. doi:10.1002/jsfa.8323
Al-Aubaidy, H. A., Dayan, A., Deseo, M. A., Itsiopoulos, C., Jamil, D., Hadi, N. R., et al. (2021). Twelve-Week Mediterranean Diet Intervention Increases Citrus Bioflavonoid Levels and Reduces Inflammation in People with Type 2 Diabetes Mellitus. Nutrients 13 (4), 1133. doi:10.3390/nu13041133
Alam, F., Shafique, Z., Amjad, S. T., and Bin Asad, M. H. H. (2019). Enzymes Inhibitors from Natural Sources with Antidiabetic Activity: A Review. Phytother. Res. 33 (1), 41–54. doi:10.1002/ptr.6211
Alzahrani, S., Zaitone, S. A., Said, E., El-Sherbiny, M., Ajwah, S., Alsharif, S. Y., et al. (2020). Protective Effect of Isoliquiritigenin on Experimental Diabetic Nephropathy in Rats: Impact on Sirt-1/NFκB Balance and NLRP3 Expression. Int. Immunopharmacol. 87, 106813. doi:10.1016/j.intimp.2020.106813
An, T., Zhang, J., Lv, B., Liu, Y., Huang, J., Lian, J., et al. (2019). Salvianolic Acid B Plays an Anti-obesity Role in High Fat Diet-Induced Obese Mice by Regulating the Expression of mRNA, circRNA, and lncRNA. PeerJ 7, e6506. doi:10.7717/peerj.6506
Athyros, V. G., Doumas, M., Imprialos, K. P., Stavropoulos, K., Georgianou, E., Katsimardou, A., et al. (2018). Diabetes and Lipid Metabolism. Horm. (Athens) 17 (1), 61–67. doi:10.1007/s42000-018-0014-8
Baek, S. Y., Lee, E. H., Oh, T. W., Do, H. J., Kim, K. Y., Park, K. I., et al. (2020). Network Pharmacology-Based Approaches of Rheum Undulatum Linne and Glycyrriza Uralensis Fischer Imply Their Regulation of Liver Failure with Hepatic Encephalopathy in Mice. Biomolecules 10 (3), 437. doi:10.3390/biom10030437
Bai, L., Li, X., He, L., Zheng, Y., Lu, H., Li, J., et al. (2019). Antidiabetic Potential of Flavonoids from Traditional Chinese Medicine: A Review. Am. J. Chin. Med. 47 (5), 933–957. doi:10.1142/s0192415x19500496
Behl, T., and Kotwani, A. (2017). Chinese Herbal Drugs for the Treatment of Diabetic Retinopathy. J. Pharm. Pharmacol. 69 (3), 223–235. doi:10.1111/jphp.12683
Byeon, J. H., Kil, J. H., Ahn, Y. C., and Son, C. G. (2019). Systematic Review of Published Data on Herb Induced Liver Injury. J. Ethnopharmacol. 233, 190–196. doi:10.1016/j.jep.2019.01.006
Cao, H., Tuo, L., Tuo, Y., Xia, Z., Fu, R., Liu, Y., et al. (2017). Immune and Metabolic Regulation Mechanism of Dangguiliuhuang Decoction against Insulin Resistance and Hepatic Steatosis. Front. Pharmacol. 8, 445. doi:10.3389/fphar.2017.00445
Cao, Y., Gu, C., Zhao, F., Tang, Y., Cui, X., Shi, L., et al. (2017). Therapeutic Effects of Cyathula Officinalis Kuan and its Active Fraction on Acute Blood Stasis Rat Model and Identification Constituents by HPLC-QTOF/MS/MS. Pharmacogn. Mag. 13 (52), 693–701. doi:10.4103/pm.pm_560_16
Carnovali, M., Banfi, G., and Mariotti, M. (2020). Liquiritigenin Reduces Osteoclast Activity in Zebrafish Model of Glucocorticoid-Induced Osteoporosis. J. Pharmacol. Sci. 143 (4), 300–306. doi:10.1016/j.jphs.2020.06.001
Carnovali, M., Luzi, L., Terruzzi, I., Banfi, G., and Mariotti, M. (2019). Liquiritigenin Reduces Blood Glucose Level and Bone Adverse Effects in Hyperglycemic Adult Zebrafish. Nutrients 11 (5), 1042. doi:10.3390/nu11051042
Castro, M. A., Llanos, M. A., Rodenak-Kladniew, B. E., Gavernet, L., Galle, M. E., and Crespo, R. (2020). Citrus Reticulata Peel Oil as an Antiatherogenic Agent: Hypolipogenic Effect in Hepatic Cells, Lipid Storage Decrease in Foam Cells, and Prevention of LDL Oxidation. Nutr. Metab. Cardiovasc. Dis. 30 (9), 1590–1599. doi:10.1016/j.numecd.2020.04.033
Chao, J., Ko, C. Y., Lin, C. Y., Tomoji, M., Huang, C. H., Chiang, H. C., et al. (2020). Ethnobotanical Survey of Natural Galactagogues Prescribed in Traditional Chinese Medicine Pharmacies in Taiwan. Front. Pharmacol. 11, 625869. doi:10.3389/fphar.2020.625869
Chen, G., Yang, X., Yang, X., Li, L., Luo, J., Dong, H., et al. (2017). Jia-Wei-Jiao-Tai-Wan Ameliorates Type 2 Diabetes by Improving β Cell Function and Reducing Insulin Resistance in Diabetic Rats. BMC Complement. Altern. Med. 17 (1), 507. doi:10.1186/s12906-017-2016-5
Chen, L., He, W., Peng, B., Yuan, M., Wang, N., Wang, J., et al. (2019). Sodium Tanshinone IIA Sulfonate Improves Post-ischemic Angiogenesis in Hyperglycemia. Biochem. Biophys. Res. Commun. 520 (3), 580–585. doi:10.1016/j.bbrc.2019.09.106
Chen, Z., Cao, Y., Zhang, Y., and Qiao, Y. (2019a). A Novel Discovery: Holistic Efficacy at the Special Organ Level of Pungent Flavored Compounds from Pungent Traditional Chinese Medicine. Int. J. Mol. Sci. 20 (3). doi:10.3390/ijms20030752
Chen, Z., Yao, L., Liu, Y., Pan, Z., Peng, S., Wan, G., et al. (2019b). Astragaloside IV Regulates NF-Κb-Mediated Cellular Senescence and Apoptosis of Hepatic Stellate Cells to Suppress PDGF-BB-Induced Activation. Exp. Ther. Med. 18 (5), 3741–3750. doi:10.3892/etm.2019.8047
Cheng, C. F., Ku, H. C., Cheng, J. J., Chao, S. W., Li, H. F., Lai, P. F., et al. (2019). Adipocyte Browning and Resistance to Obesity in Mice Is Induced by Expression of ATF3. Commun. Biol. 2, 389. doi:10.1038/s42003-019-0624-y
Cheng, X., Qiu, L., and Wang, F. (2020a). 18α-Glycyrrhetinic Acid (GA) Ameliorates Fructose-Induced Nephropathy in Mice by Suppressing Oxidative Stress, Dyslipidemia and Inflammation. Biomed. Pharmacother. 125, 109702. doi:10.1016/j.biopha.2019.109702
Cheng, X., Shi, S., Su, J., Xu, Y., Ordaz-Ortiz, J. J., Li, N., et al. (2020b). Structural Characterization of a Heteropolysaccharide from Fruit of Chaenomelese Speciosa (Sweet) Nakai and its Antitumor Activity. Carbohydr. Polym. 236, 116065. doi:10.1016/j.carbpol.2020.116065
Chinese Pharmacopoeia Commission (2020). Pharmacopoeia of People's Republic of China. People’s Republic of China: China Medical Science Press.
Choi, J. H., Lim, S. K., Kim, D. I., Park, M. J., Kim, Y. K., Lee, A. C., et al. (2017). Safflower Bud Inhibits RANKL-Induced Osteoclast Differentiation and Prevents Bone Loss in Ovariectomized Mice. Phytomedicine 34, 6–13. doi:10.1016/j.phymed.2017.07.006
Chu, S. M., Shih, W. T., Yang, Y. H., Chen, P. C., and Chu, Y. H. (2015). Use of Traditional Chinese Medicine in Patients with Hyperlipidemia: A Population-Based Study in Taiwan. J. Ethnopharmacol. 168, 129–135. doi:10.1016/j.jep.2015.03.047
Dehghani, S., Mehri, S., and Hosseinzadeh, H. (2019). The Effects of Crataegus Pinnatifida (Chinese Hawthorn) on Metabolic Syndrome: A Review. Iran. J. Basic Med. Sci. 22 (5), 460–468. doi:10.22038/ijbms.2019.31964.7678
Deng, Y., Huang, L., Zhang, C., Xie, P., Cheng, J., Wang, X., et al. (2020). Novel Polysaccharide from Chaenomeles Speciosa Seeds: Structural Characterization, α-amylase and α-glucosidase Inhibitory Activity Evaluation. Int. J. Biol. Macromol. 153, 755–766. doi:10.1016/j.ijbiomac.2020.03.057
Dhuique-Mayer, C., Gence, L., Portet, K., Tousch, D., and Poucheret, P. (2020). Preventive Action of Retinoids in Metabolic Syndrome/type 2 Diabetic Rats Fed with Citrus Functional Food Enriched in β-cryptoxanthin. Food Funct. 11 (10), 9263–9271. doi:10.1039/d0fo02430a
Di Giantomasso, D., May, C. N., and Bellomo, R. (2002). Norepinephrine and Vital Organ Blood Flow. Intensive Care Med. 28 (12), 1804–1809. doi:10.1007/s00134-002-1444-x
Dincer, Y., and Yuksel, S. (2021). Antiobesity Effects of Phytochemicals from an Epigenetic Perspective. Nutrition 84, 111119. doi:10.1016/j.nut.2020.111119
Dong, X. L., Yu, W. X., Li, C. M., Zhou, L. P., and Wong, M. S. (2020). Chuanxiong (Rhizome of Ligusticum Chuanxiong) Protects Ovariectomized Hyperlipidemic Rats from Bone Loss. Am. J. Chin. Med. 48 (2), 463–485. doi:10.1142/s0192415x2050024x
Du, G., Song, J., Du, L., Zhang, L., Qiang, G., Wang, S., et al. (2020). Chemical and Pharmacological Research on the Polyphenol Acids Isolated from Danshen: A Review of Salvianolic Acids. Adv. Pharmacol. 87, 1–41. doi:10.1016/bs.apha.2019.12.004
Fan, H., Li, M., Yu, L., Jin, W., Yang, J., Zhang, Y., et al. (2018). Effects of Danhong Injection on Platelet Aggregation in Hyperlipidemia Rats. J. Ethnopharmacol. 212, 67–73. doi:10.1016/j.jep.2017.10.017
Fan, J. R., Kuang, Y., Dong, Z. Y., Yi, Y., Zhou, Y. X., Li, B., et al. (2020). Prenylated Phenolic Compounds from the Aerial Parts of Glycyrrhiza Uralensis as PTP1B and α-Glucosidase Inhibitors. J. Nat. Prod. 83 (4), 814–824. doi:10.1021/acs.jnatprod.9b00262
Feng, H., Fan, J., Lin, L., Liu, Y., Chai, D., and Yang, J. (2019). Immunomodulatory Effects of Phosphorylated Radix Cyathulae Officinalis Polysaccharides in Immunosuppressed Mice. Molecules 24 (22). doi:10.3390/molecules24224150
Feng, H., McDonough, S. P., Fan, J., Yang, S., Zhao, X., Lu, Y., et al. (2017). Phosphorylated Radix Cyathulae Officinalis Polysaccharides Act as Adjuvant via Promoting Dendritic Cell Maturation. Molecules 22 (1), 106. doi:10.3390/molecules22010106
Feng, S. H., Zhao, B., Zhan, X., Motanyane, R., Wang, S. M., and Li, A. (2021). Danggui Buxue Decoction in the Treatment of Metastatic Colon Cancer: Network Pharmacology Analysis and Experimental Validation. Drug Des. Devel Ther. 15, 705–720. doi:10.2147/dddt.S293046
Fernandez, M. L., Thomas, M. S., Lemos, B. S., DiMarco, D. M., Missimer, A., Melough, M., et al. (2018). TA-65, A Telomerase Activator Improves Cardiovascular Markers in Patients with Metabolic Syndrome. Curr. Pharm. Des. 24 (17), 1905–1911. doi:10.2174/1381612824666180316114832
Figarska, S. M., Vonk, J. M., and Boezen, H. M. (2014). NFE2L2 Polymorphisms, Mortality, and Metabolism in the General Population. Physiol. Genomics 46 (12), 411–417. doi:10.1152/physiolgenomics.00178.2013
Fürstenau, C. R., de Souza, I. C. C., and de Oliveira, M. R. (2019). Tanshinone I Induces Mitochondrial Protection by a Mechanism Involving the Nrf2/GSH Axis in the Human Neuroblastoma SH-Sy5y Cells Exposed to Methylglyoxal. Neurotox. Res. 36 (3), 491–502. doi:10.1007/s12640-019-00091-1
Gandhi, G. R., Vasconcelos, A. B. S., Wu, D. T., Li, H. B., Antony, P. J., Li, H., et al. (2020). Citrus Flavonoids as Promising Phytochemicals Targeting Diabetes and Related Complications: A Systematic Review of In Vitro and In Vivo Studies. Nutrients 12 (10), 2907. doi:10.3390/nu12102907
Gao, J., Wang, T., Wang, C., Wang, S., Wang, W., Ma, D., et al. (2019). Effects of Tianshu Capsule on Spontaneously Hypertensive Rats as Revealed by 1H-NMR-Based Metabolic Profiling. Front. Pharmacol. 10, 989. doi:10.3389/fphar.2019.00989
Gao, K., Yang, R., Zhang, J., Wang, Z., Jia, C., Zhang, F., et al. (2018). Effects of Qijian Mixture on Type 2 Diabetes Assessed by Metabonomics, Gut Microbiota and Network Pharmacology. Pharmacol. Res. 130, 93–109. doi:10.1016/j.phrs.2018.01.011
Ge, H., Chen, Y., Chen, J., Tian, J., Liang, X., and Chen, L. (2018). Evaluation of Antioxidant Activities of Ethanol Extract from Ligusticum Subjected to Iin-Vvitro Gastrointestinal Digestion. Food Chem. Toxicol. 119, 417–424. doi:10.1016/j.fct.2017.12.035
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., et al. (2019). 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 73(24), e285-e350. doi: doi:doi:10.1016/j.jacc.2018.11.003
Guan, Y., and Wang, X. (2021). Salvianic Acid A Regulates High-Glucose-Treated Endothelial Progenitor Cell Dysfunction via the AKT/Endothelial Nitric Oxide Synthase (eNOS) Pathway. Med. Sci. Monit. 27, e928153. doi:10.12659/msm.928153
Guo, J., Chen, J., Ren, W., Zhu, Y., Zhao, Q., Zhang, K., et al. (2020). Citrus Flavone Tangeretin Is a Potential Insulin Sensitizer Targeting Hepatocytes through Suppressing MEK-Erk1/2 Pathway. Biochem. Biophys. Res. Commun. 529 (2), 277–282. doi:10.1016/j.bbrc.2020.05.212
Guo, M., Liu, Y., Gao, Z. Y., and Shi, D. Z. (2014). Chinese Herbal Medicine on Dyslipidemia: Progress and Perspective. Evid. Based Complement. Altern. Med. 2014, 163036. doi:10.1155/2014/163036
Guo, Y., Sun, J., Zhang, R., Yang, P., Zhang, S., and Wu, Z. (2021). Salvia Miltiorrhiza Improves Type 2 Diabetes. Med. Baltim. 100 (6), e23843. doi:10.1097/md.0000000000023843
Hager, M. R., Narla, A. D., and Tannock, L. R. (2017). Dyslipidemia in Patients with Chronic Kidney Disease. Rev. Endocr. Metab. Disord. 18 (1), 29–40. doi:10.1007/s11154-016-9402-z
Han, D., Wei, J., Zhang, R., Ma, W., Shen, C., Feng, Y., et al. (2016). Hydroxysafflor Yellow A Alleviates Myocardial Ischemia/reperfusion in Hyperlipidemic Animals through the Suppression of TLR4 Signaling. Sci. Rep. 6, 35319. doi:10.1038/srep35319
Hao, X., Pu, Z., Cao, G., You, D., Zhou, Y., Deng, C., et al. (2020). Tanshinone and Salvianolic Acid Biosynthesis Are Regulated by SmMYB98 in Salvia Miltiorrhiza Hairy Roots. J. Adv. Res. 23, 1–12. doi:10.1016/j.jare.2020.01.012
Hassan, S., Sajjad, N., Khan, S. U., Gupta, S., Bhat, M. A., Ali, R., et al. (2020). Dipsacus Inermis Wall. Modulates Inflammation by Inhibiting NF-Κb Pathway: An In Vitro and In Vivo Study. J. Ethnopharmacol. 254, 112710. doi:10.1016/j.jep.2020.112710
He, J., Li, X., Wang, Z., Bennett, S., Chen, K., Xiao, Z., et al. (2019). Therapeutic Anabolic and Anticatabolic Benefits of Natural Chinese Medicines for the Treatment of Osteoporosis. Front. Pharmacol. 10, 1344. doi:10.3389/fphar.2019.01344
He, K. Q., Li, W. Z., Chai, X. Q., Yin, Y. Y., Jiang, Y., and Li, W. P. (2018). Astragaloside IV Prevents Kidney Injury Caused by Iatrogenic Hyperinsulinemia in a Streptozotocininduced Diabetic Rat Model. Int. J. Mol. Med. 41 (2), 1078–1088. doi:10.3892/ijmm.2017.3265
Hendrich, A. B., Strugała, P., Dudra, A., Kucharska, A. Z., Sokół-Łętowska, A., Wojnicz, D., et al. (2020). Microbiological, Antioxidant and Lipoxygenase-1 Inhibitory Activities of Fruit Extracts of Chosen Rosaceae Family Species. Adv. Clin. Exp. Med. 29 (2), 215–224. doi:10.17219/acem/115086
Hoekstra, J. W., Van Ligten, P., Neumar, R., Werman, H. A., Anderson, J., and Brown, C. G. (1990). Effect of High Dose Norepinephrine versus Epinephrine on Cerebral and Myocardial Blood Flow during CPR. Resuscitation 19 (3), 227–240. doi:10.1016/0300-9572(90)90104-m
Hu, F. P., Liao, C. C., Chen, T. L., Yeh, C. C., Shi, L., and Shih, C. C. (2020). Prevalence, Expenditures, and Associated Factors of Purchasing Non-prescribed Chinese Herbal Medicine in Taiwan. PLoS One 15 (10), e0240311. doi:10.1371/journal.pone.0240311
Hu, H., Zhu, Q., Su, J., Wu, Y., Zhu, Y., Wang, Y., et al. (2017). Effects of an Enriched Extract of Paeoniflorin, a Monoterpene Glycoside Used in Chinese Herbal Medicine, on Cholesterol Metabolism in a Hyperlipidemic Rat Model. Med. Sci. Monit. 23, 3412–3427. doi:10.12659/msm.905544
Hu, Y., and Wang, J. (2019). Interactions between Clopidogrel and Traditional Chinese Medicine. J. Thromb. Thrombolysis 48 (3), 491–499. doi:10.1007/s11239-019-01945-3
Hua, Y. L., Ma, Q., Zhang, X. S., Yao, W. L., Ji, P., Hu, J. J., et al. (2019). Urinary Metabolomics Analysis Reveals the Effect of Volatile Oil from Angelica Sinensis on LPS-Induced Inflammation Rats. Biomed. Chromatogr. 33 (2), e4402. doi:10.1002/bmc.4402
Huang, F., Xu, C., Li, B., Wang, S., Du, X., Guo, X., et al. (2018). Acupoint Injection of BMSCs Combined with Chinese Herbs for Capillary Density in Ischemic Hind Limb of Diabetes Mellitus Rats. Zhongguo Zhen Jiu 38 (9), 969–977. doi:10.13703/j.0255-2930.2018.09.017
Huang, W., He, J., Nisar, M. F., Li, H., and Wan, C. (2018). Phytochemical and Pharmacological Properties of Chaenomeles Speciosa: An Edible Medicinal Chinese Mugua. Evid. Based Complement. Altern. Med. 2018, 9591845. doi:10.1155/2018/9591845
Huang, W. C., Liao, K. Y., Hsieh, S. K., Pan, P. H., Kuan, Y. H., Liao, S. L., et al. (2021). Magnesium Lithospermate B Supplementation Improved Prenatal Bisphenol A Exposure-Induced Metabolic Abnormalities in Male Offspring. Environ. Toxicol. 36 (9), 1932–1943. doi:10.1002/tox.23313
Hussain, A., Cho, J. S., Kim, J.-S., and Lee, Y. I. (2021). Protective Effects of Polyphenol Enriched Complex Plants Extract on Metabolic Dysfunctions Associated with Obesity and Related Nonalcoholic Fatty Liver Diseases in High Fat Diet-Induced C57BL/6 Mice. Molecules 26 (2), 302. doi:10.3390/molecules26020302
Igarashi, Y., Iida, S., Dai, J., Huo, J., Cui, X., Sawashita, J., et al. (2021). Glavonoid-rich Oil Supplementation Reduces Stearoyl-Coenzyme A Desaturase 1 Expression and Improves Systemic Metabolism in Diabetic, Obese KK-Ay Mice. Biomed. Pharmacother. 140, 111714. doi:10.1016/j.biopha.2021.111714
Jia, N., Qiao, H., Zhu, W., Zhu, M., Meng, Q., Lu, Q., et al. (2019). Antioxidant, Immunomodulatory, Oxidative Stress Inhibitory and Iron Supplementation Effect of Astragalus Membranaceus Polysaccharide-Iron (III) Complex on Iron-Deficiency Anemia Mouse Model. Int. J. Biol. Macromol. 132, 213–221. doi:10.1016/j.ijbiomac.2019.03.196
Jia, Q., Zhu, R., Tian, Y., Chen, B., Li, R., Li, L., et al. (2019). Salvia Miltiorrhiza in Diabetes: A Review of its Pharmacology, Phytochemistry, and Safety. Phytomedicine 58, 152871. doi:10.1016/j.phymed.2019.152871
Jin, J., Zhang, Z., Chen, J., Liu, Y., Chen, Q., and Wang, Q. (2019). Jixuepaidu Tang-1 Inhibits Epithelial-Mesenchymal Transition and Alleviates Renal Damage in DN Mice through Suppressing Long Non-coding RNA LOC498759. Cell. Cycle 18 (22), 3125–3136. doi:10.1080/15384101.2019.1669986
Jung, H. A., Ali, M. Y., Bhakta, H. K., Min, B. S., and Choi, J. S. (2017). Prunin Is a Highly Potent Flavonoid from Prunus Davidiana Stems that Inhibits Protein Tyrosine Phosphatase 1B and Stimulates Glucose Uptake in Insulin-Resistant HepG2 Cells. Arch. Pharm. Res. 40 (1), 37–48. doi:10.1007/s12272-016-0852-3
Jung, H. A., Ali, M. Y., and Choi, J. S. (2016). Promising Inhibitory Effects of Anthraquinones, Naphthopyrone, and Naphthalene Glycosides, from Cassia Obtusifolia on α-Glucosidase and Human Protein Tyrosine Phosphatases 1B. Molecules 22 (1), 28. doi:10.3390/molecules22010028
Kambalachenu, H. R., Reddy, T. M., Rao, S. D., Dorababu, K., Reddy, K. K., and Sarma, K. V. S. (2018). A Randomized, Double Blind, Placebo Controlled, Crossover Study to Assess the Safety and Beneficial Effects of Cassia Tora Supplementation in Healthy Adults. Rev. Recent Clin. Trials 13 (1), 69–78. doi:10.2174/1574887112666171120094539
Karr, S. (2017). Epidemiology and Management of Hyperlipidemia. Am. J. Manag. Care 23 (9 Suppl. l), S139–s148.
Ko, C.-Y., Chao, J., Chen, P.-Y., Su, S.-Y., Maeda, T., Lin, C.-Y., et al. (2021). Ethnobotanical Survey on Skin Whitening Prescriptions of Traditional Chinese Medicine in Taiwan. Front. Pharmacol. 12. doi:10.3389/fphar.2021.736370
Ko, E., Um, M. Y., Choi, M., Han, T., Kim, I. H., and Shin, S. (2020). Cassia Tora Seed Improves Pancreatic Mitochondrial Function Leading to Recovery of Glucose Metabolism. Am. J. Chin. Med. 48 (3), 615–629. doi:10.1142/s0192415x20500317
Kong, F., Ding, Z., Zhang, K., Duan, W., Qin, Y., Su, Z., et al. (2020). Optimization of Extraction Flavonoids from Exocarpium Citri Grandis and Evaluation its Hypoglycemic and Hypolipidemic Activities. J. Ethnopharmacol. 262, 113178. doi:10.1016/j.jep.2020.113178
Kopin, L., and Lowenstein, C. (2017). Dyslipidemia. Ann. Intern Med. 167 (11), ITC81–ITC96. doi:10.7326/AITC201712050
Kumar, R., Malik, S., Tiwari, R., Zhautivova, S. B., Rakhimovna, A. H., Raj, T., et al. (2021). Pathophysiology of Cardiovascular Diseases and the Role of Vitamins, and Herbal Extracts in the Reduction of Cardiovascular Risks. Chamc 19, 175–186. doi:10.2174/1871525718666201217102638
Lee, C. L., Hung, Y. P., Hsu, Y. W., and Pan, T. M. (2013). Monascin and Ankaflavin Have More Anti-atherosclerosis Effect and Less Side Effect Involving Increasing Creatinine Phosphokinase Activity Than Monacolin K under the Same Dosages. J. Agric. Food Chem. 61 (1), 143–150. doi:10.1021/jf304346r
Lee, E. J., Oh, H., Kang, B. G., Kang, M. K., Kim, D. Y., Kim, Y. H., et al. (2018). Lipid-Lowering Effects of Medium-Chain Triglyceride-Enriched Coconut Oil in Combination with Licorice Extracts in Experimental Hyperlipidemic Mice. J. Agric. Food Chem. 66 (40), 10447–10457. doi:10.1021/acs.jafc.8b04080
Lee, H. E., Yang, G., Han, S. H., Lee, J. H., An, T. J., Jang, J. K., et al. (2018). Anti-obesity Potential of Glycyrrhiza Uralensis and Licochalcone A through Induction of Adipocyte Browning. Biochem. Biophys. Res. Commun. 503 (3), 2117–2123. doi:10.1016/j.bbrc.2018.07.168
Lee, M., Li, H., Zhao, H., Suo, M., and Liu, D. (2020a). Effects of Hydroxysafflor Yellow A on the PI3K/AKT Pathway and Apoptosis of Pancreatic β-Cells in Type 2 Diabetes Mellitus Rats. Diabetes Metab. Syndr. Obes. 13, 1097–1107. doi:10.2147/dmso.S246381
Lee, M., Zhao, H., Liu, X., Liu, D., Chen, J., Li, Z., et al. (2020b). Protective Effect of Hydroxysafflor Yellow A on Nephropathy by Attenuating Oxidative Stress and Inhibiting Apoptosis in Induced Type 2 Diabetes in Rat. Oxid. Med. Cell. Longev. 2020, 7805393. doi:10.1155/2020/7805393
Lee, S. R., Jeon, H., Kwon, J. E., Suh, H., Kim, B. H., Yun, M. K., et al. (2020). Anti-osteoporotic Effects of Salvia Miltiorrhiza Bunge EtOH Extract Both in Ovariectomized and Naturally Menopausal Mouse Models. J. Ethnopharmacol. 258, 112874. doi:10.1016/j.jep.2020.112874
Lee, Y. H., Jin, B., Lee, S. H., Song, M., Bae, H., Min, B. J., et al. (2016). Herbal Formula HT048 Attenuates Diet-Induced Obesity by Improving Hepatic Lipid Metabolism and Insulin Resistance in Obese Rats. Molecules 21 (11). doi:10.3390/molecules21111424
Leng, B., Tang, F., Lu, M., Zhang, Z., Wang, H., and Zhang, Y. (2018). Astragaloside IV Improves Vascular Endothelial Dysfunction by Inhibiting the TLR4/NF-Κb Signaling Pathway. Life Sci. 209, 111–121. doi:10.1016/j.lfs.2018.07.053
Li, A., Wang, N., Li, N., Li, B., Yan, F., Song, Y., et al. (2021). Modulation Effect of Chenpi Extract on Gut Microbiota in High‐fat Diet‐induced Obese C57BL/6 Mice. J. Food Biochem. 45 (4), e13541. doi:10.1111/jfbc.13541
Li, C. L., Liu, B., Wang, Z. Y., Xie, F., Qiao, W., Cheng, J., et al. (2020). Salvianolic Acid B Improves Myocardial Function in Diabetic Cardiomyopathy by Suppressing IGFBP3. J. Mol. Cell. Cardiol. 139, 98–112. doi:10.1016/j.yjmcc.2020.01.009
Li, D., Chen, Y. G., Zhang, C. J., Tian, J., and Li, X. (2017). Safflower Extract and Aceglutamide Injection Promoting Recovery of Peripheral Innervations via Vascular Endothelial Growth Factor-B Signaling in Diabetic Mice. Chin. Med. J. Engl. 130 (23), 2829–2835. doi:10.4103/0366-6999.219143
Li, N. Y., Yu, H., Li, X. L., Wang, Q. Y., Zhang, X. W., Ma, R. X., et al. (2018). Astragalus Membranaceus Improving Asymptomatic Left Ventricular Diastolic Dysfunction in Postmenopausal Hypertensive Women with Metabolic Syndrome: A Prospective, Open-Labeled, Randomized Controlled Trial. Chin. Med. J. Engl. 131 (5), 516–526. doi:10.4103/0366-6999.226077
Li, X., Qin, X., Tian, J., Gao, X., Wu, X., Du, G., et al. (2020). Liquiritin Protects PC12 cells from Corticosterone-Induced Neurotoxicity via Regulation of Metabolic Disorders, Attenuation ERK1/2-NF-Κb Pathway, Activation Nrf2-Keap1 Pathway, and Inhibition Mitochondrial Apoptosis Pathway. Food Chem. Toxicol. 146, 111801. doi:10.1016/j.fct.2020.111801
Li, Y., Zheng, D., Shen, D., Zhang, X., Zhao, X., and Liao, H. (2020). Protective Effects of Two Safflower Derived Compounds, Kaempferol and Hydroxysafflor Yellow A, on Hyperglycaemic Stress-Induced Podocyte Apoptosis via Modulating of Macrophage M1/M2 Polarization. J. Immunol. Res. 2020, 2462039. doi:10.1155/2020/2462039
Liao, F., Liu, Y., Liu, H. H., Hu, J., Zhao, S., and Yang, S. M. (2019). Effect of Angelica Sinensis Polysaccharide on the Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells of Rats with High Glucose Levels. Hua Xi Kou Qiang Yi Xue Za Zhi 37 (2), 193–199. doi:10.7518/hxkq.2019.02.012
Liao, W. T., Su, C. C., Lee, M. T., Li, C. J., Lin, C. L., Chiang, J. H., et al. (2019). Integrative Chinese Herbal Medicine Therapy Reduced the Risk of Type 2 Diabetes Mellitus in Patients with Polycystic Ovary Syndrome: A Nationwide Matched Cohort Study. J. Ethnopharmacol. 243, 112091. doi:10.1016/j.jep.2019.112091
Lien, A. S., Jiang, Y. D., Mou, C. H., Sun, M. F., Gau, B. S., and Yen, H. R. (2016). Integrative Traditional Chinese Medicine Therapy Reduces the Risk of Diabetic Ketoacidosis in Patients with Type 1 Diabetes Mellitus. J. Ethnopharmacol. 191, 324–330. doi:10.1016/j.jep.2016.06.051
Lin, C. H., Lin, T. H., and Pan, T. M. (2017). Alleviation of Metabolic Syndrome by Monascin and Ankaflavin: the Perspective of Monascus Functional Foods. Food Funct. 8 (6), 2102–2109. doi:10.1039/c7fo00406k
Liu, C., Sun, Y., Li, Y., Yang, W., Zhang, M., Xiong, C., et al. (2012). The Relationship between Cold-Hot Nature and Nutrient Contents of Foods. Nutr. Dietetics 69 (1), 64–68. doi:10.1111/j.1747-0080.2011.01565.x
Liu, J., Yue, S., Yang, Z., Feng, W., Meng, X., Wang, A., et al. (2018). Oral Hydroxysafflor Yellow A Reduces Obesity in Mice by Modulating the Gut Microbiota and Serum Metabolism. Pharmacol. Res. 134, 40–50. doi:10.1016/j.phrs.2018.05.012
Liu, J., Feng, W., and Peng, C. (2020). A Song of Ice and Fire: Cold and Hot Properties of Traditional Chinese Medicines. Front. Pharmacol. 11, 598744. doi:10.3389/fphar.2020.598744
Liu, J., Nile, S. H., Xu, G., Wang, Y., and Kai, G. (2021). Systematic Exploration of Astragalus Membranaceus and Panax Ginseng as Immune Regulators: Insights from the Comparative Biological and Computational Analysis. Phytomedicine 86, 153077. doi:10.1016/j.phymed.2019.153077
Liu, L., Tao, W., Pan, W., Li, L., Yu, Q., Zhang, D., et al. (2018). Hydroxysafflor Yellow A Promoted Bone Mineralization and Inhibited Bone Resorption Which Reversed Glucocorticoids-Induced Osteoporosis. Biomed. Res. Int. 2018, 6762146. doi:10.1155/2018/6762146
Liu, S., Fang, T., Yang, L., Chen, Z., Mu, S., and Fu, Q. (2018). Gastrodin Protects MC3T3-E1 Osteoblasts from Dexamethasone-Induced Cellular Dysfunction and Promotes Bone Formation via Induction of the NRF2 Signaling Pathway. Int. J. Mol. Med. 41 (4), 2059–2069. doi:10.3892/ijmm.2018.3414
Liu, Y., Wang, A., Wen, L., Yang, Z., Yang, X., Zhang, X., et al. (2019). A Chinese Medicine Formula (Jinqi Jiangtang Tablet): A Review on its Chemical Constituents, Quality Control, Pharmacokinetics Studies, Pharmacological Properties and Clinical Applications. J. Ethnopharmacol. 236, 1–8. doi:10.1016/j.jep.2019.02.038
Liu, Y. Q., Cheng, M. C., Wang, L. X., Zhao, N., Xiao, H. B., and Wang, Z. T. (2008). Functional Analysis of Cultured Neural Cells for Evaluating Cold/cool- and Hot/warm-Natured Chinese Herbs. Am. J. Chin. Med. 36 (4), 771–781. doi:10.1142/s0192415x08006223
Lu, H. L., Su, Y. C., Lin, M. C., Sun, M. F., and Huang, S. T. (2020). Integrating Chinese and Western Medicines Reduced the Incidence of Hepatocellular Carcinoma in Patients with Diabetes Mellitus: A Taiwanese Population-Based Cohort Study. Complement. Ther. Med. 49, 102332. doi:10.1016/j.ctim.2020.102332
Lu, J. F., Zhu, M. Q., Zhang, H., Liu, H., Xia, B., Wang, Y. L., et al. (2020). Neohesperidin Attenuates Obesity by Altering the Composition of the Gut Microbiota in High-Fat Diet-Fed Mice. Faseb J. 34 (9), 12053–12071. doi:10.1096/fj.201903102RR
Luo, Z., Guo, Z., Xiao, T., Liu, H., Su, G., and Zhao, Y. (2019). Enrichment of Total Flavones and Licochalcone A from Licorice Residues and its Hypoglycemic Activity. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 1114-1115, 134–145. doi:10.1016/j.jchromb.2019.01.026
Ma, J., He, W., Gao, C., Yu, R., Xue, P., and Niu, Y. (2019). Glucosides of Chaenomeles Speciosa Attenuate Ischemia/reperfusion-Induced Brain Injury by Regulating NF-Κb P65/TNF-α in Mouse Model. Zhejiang Da Xue Xue Bao Yi Xue Ban. 48 (3), 289–295. doi:10.3785/j.issn.1008-9292.2019.06.09
Ma, L., Luo, S., Zhou, L., Zhao, Z., Li, Q., Xu, L., et al. (2019). TanshinoneⅡA Phenanthroimidazole Derivative Polarizes Macrophage to Improve Metabolic Homeostasis. Biochem. Biophys. Res. Commun. 514 (3), 861–867. doi:10.1016/j.bbrc.2019.05.056
Ma, Q., Yang, Q., Chen, J., Yu, C., Zhang, L., Zhou, W., et al. (2020). Salvianolic Acid A Ameliorates Early-Stage Atherosclerosis Development by Inhibiting NLRP3 Inflammasome Activation in Zucker Diabetic Fatty Rats. Molecules 25 (5), 1089. doi:10.3390/molecules25051089
Mato Mofo, E. P., Essop, M. F., and Owira, P. M. O. (2020). Citrus Fruit-Derived Flavonoid Naringenin and the Expression of Hepatic Organic Cation Transporter 1 Protein in Diabetic Rats Treated with Metformin. Basic Clin. Pharmacol. Toxicol. 127 (3), 211–220. doi:10.1111/bcpt.13407
Meephat, S., Prasatthong, P., Rattanakanokchai, S., Bunbupha, S., Maneesai, P., and Pakdeechote, P. (2021). Diosmetin Attenuates Metabolic Syndrome and Left Ventricular Alterations via the Suppression of Angiotensin II/AT1 Receptor/gp91phox/p-NF-Κb Protein Expression in High-Fat Diet Fed Rats. Food Funct. 12 (4), 1469–1481. doi:10.1039/d0fo02744h
Meng, X., Wang, Z., Liang, S., Tang, Z., Liu, J., Xin, Y., et al. (2019). Hepatoprotective Effect of a Polysaccharide from Radix Cyathulae Officinalis Kuan against CCl4-Induced Acute Liver Injury in Rat. Int. J. Biol. Macromol. 132, 1057–1067. doi:10.1016/j.ijbiomac.2019.04.018
Meng, Y., Du, Z., Li, Y., Gao, P., Song, J., Lu, Y., et al. (2020). The Synergistic Mechanism of Total Saponins and Flavonoids in Notoginseng-Safflower Pair against Myocardial Ischemia Uncovered by an Integrated Metabolomics Strategy. Biomed. Pharmacother. 130, 110574. doi:10.1016/j.biopha.2020.110574
Meng, Y., Du, Z., Li, Y., Wang, L., Gao, P., Gao, X., et al. (2018). Integration of Metabolomics with Pharmacodynamics to Elucidate the Anti-myocardial Ischemia Effects of Combination of Notoginseng Total Saponins and Safflower Total Flavonoids. Front. Pharmacol. 9, 667. doi:10.3389/fphar.2018.00667
Miao, J., Wei, K., Li, X., Zhao, C., Chen, X., Mao, X., et al. (2017). Effect of Boiling and Drying Process on Chemical Composition and Antioxidant Activity of Chaenomeles Speciosa. J. Food Sci. Technol. 54 (9), 2758–2768. doi:10.1007/s13197-017-2712-7
Naeini, F., Namkhah, Z., Ostadrahimi, A., Tutunchi, H., and Hosseinzadeh-Attar, M. J. (2021). A Comprehensive Systematic Review of the Effects of Naringenin, a Citrus-Derived Flavonoid, on Risk Factors for Nonalcoholic Fatty Liver Disease. Adv. Nutr. 12 (2), 413–428. doi:10.1093/advances/nmaa106
National Administration of Traditional Chinese Medicine “Chinese Materia Medica” Editorial Board (1999). Chinese Materia Medica. Shanghai Scientific and Technical Publishers.
National Center for Complementary and Integrative Health (2019). Traditional Chinese Medicine: What You Need to Know. [Online]. Available: https://www.nccih.nih.gov/health/traditional-chinese-medicine-what-you-need-to-know (Accessed August 16, 2021).
Nie, T., Zhao, S., Mao, L., Yang, Y., Sun, W., Lin, X., et al. (2018). The Natural Compound, Formononetin, Extracted from Astragalus Membranaceus Increases Adipocyte Thermogenesis by Modulating PPARγ Activity. Br. J. Pharmacol. 175 (9), 1439–1450. doi:10.1111/bph.14139
Nikles, S., Monschein, M., Zou, H., Liu, Y., He, X., Fan, D., et al. (2017). Metabolic Profiling of the Traditional Chinese Medicine Formulation Yu Ping Feng San for the Identification of Constituents Relevant for Effects on Expression of TNF-α, IFN-γ, IL-1β and IL-4 in U937 Cells. J. Pharm. Biomed. Anal. 145, 219–229. doi:10.1016/j.jpba.2017.03.049
Nimrouzi, M., Ruyvaran, M., Zamani, A., Nasiri, K., and Akbari, A. (2020). Oil and Extract of Safflower Seed Improve Fructose Induced Metabolic Syndrome through Modulating the Homeostasis of Trace Elements, TNF-α and Fatty Acids Metabolism. J. Ethnopharmacol. 254, 112721. doi:10.1016/j.jep.2020.112721
Nöst, X., Pferschy-Wenzig, E. M., Nikles, S., He, X., Fan, D., Lu, A., et al. (2019). Identification of Constituents Affecting the Secretion of Pro-inflammatory Cytokines in LPS-Induced U937 Cells by UHPLC-HRMS-Based Metabolic Profiling of the Traditional Chinese Medicine Formulation Huangqi Jianzhong Tang. Molecules 24 (17), 3116. doi:10.3390/molecules24173116
Nowicka, P., Wojdyło, A., and Laskowski, P. (2018). Inhibitory Potential against Digestive Enzymes Linked to Obesity and Type 2 Diabetes and Content of Bioactive Compounds in 20 Cultivars of the Peach Fruit Grown in Poland. Plant Foods Hum. Nutr. 73 (4), 314–320. doi:10.1007/s11130-018-0688-8
Nozaki, T., Minaguchi, J., Takehana, K., and Ueda, H. (2017). Anti-diabetic Activities of Traditional Chinese Herbal Medicine in Streptozotocin-Induced Diabetic Rats. Okajimas Folia Anat. Jpn. 93 (4), 111–118. doi:10.2535/ofaj.93.111
O'Brien, K. A. (2010). Alternative Perspectives: How Chinese Medicine Understands Hypercholesterolemia. Cholesterol 2010, 723289. doi:10.1155/2010/723289
Orgah, J. O., He, S., Wang, Y., Jiang, M., Wang, Y., Orgah, E. A., et al. (2020). Pharmacological Potential of the Combination of Salvia Miltiorrhiza (Danshen) and Carthamus tinctorius (Honghua) for Diabetes Mellitus and its Cardiovascular Complications. Pharmacol. Res. 153, 104654. doi:10.1016/j.phrs.2020.104654
Patrono, C. (2016). Cardiovascular Effects of Cyclooxygenase-2 Inhibitors: A Mechanistic and Clinical Perspective. Br. J. Clin. Pharmacol. 82 (4), 957–964. doi:10.1111/bcp.13048
Qin, T., Wu, L., Hua, Q., Song, Z., Pan, Y., and Liu, T. (2020). Prediction of the Mechanisms of Action of Shenkang in Chronic Kidney Disease: A Network Pharmacology Study and Experimental Validation. J. Ethnopharmacol. 246, 112128. doi:10.1016/j.jep.2019.112128
Rai, U., Kosuru, R., Prakash, S., Singh, S. P., Birla, H., Tiwari, V., et al. (2019). Tetramethylpyrazine Prevents Diabetes by Activating PI3K/Akt/GLUT-4 Signalling in Animal Model of Type-2 Diabetes. Life Sci. 236, 116836. doi:10.1016/j.lfs.2019.116836
Rani, R., Dahiya, S., Dhingra, D., Dilbaghi, N., Kim, K. H., and Kumar, S. (2017). Evaluation of Anti-diabetic Activity of Glycyrrhizin-Loaded Nanoparticles in Nicotinamide-Streptozotocin-Induced Diabetic Rats. Eur. J. Pharm. Sci. 106, 220–230. doi:10.1016/j.ejps.2017.05.068
Rašlová, K. (2016). Diabetes and Dyslipidemia: Why Are They So Closely Related? Vnitr Lek. 62 (11), 908–911.
Reiter-Brennan, C., Osei, A. D., Iftekhar Uddin, S. M., Orimoloye, O. A., Obisesan, O. H., Mirbolouk, M., et al. (2020). ACC/AHA Lipid Guidelines: Personalized Care to Prevent Cardiovascular Disease. Cleve Clin. J. Med. 87 (4), 231–239. doi:10.3949/ccjm.87a.19078
Ren, D. D., Li, J., Chang, B., Li, C. S., and Yang, J. H. (2017). Early Intervention with Didang Decoction Delays Macrovascular Lesions in Diabetic Rats through Regulating AMP-Activated Protein Kinase Signaling Pathway. Chin. J. Nat. Med. 15 (11), 847–854. doi:10.1016/s1875-5364(18)30018-9
Rho, T. W., Lee, S. Y., Han, S. Y., Kim, J. H., Lee, K. H., Kim, D. S., et al. (2017). Glycyrrhizae Radix Inhibits Osteoclast Differentiation by Inhibiting C-fos-dependent NFATc1 Expression. Am. J. Chin. Med. 45 (2), 283–298. doi:10.1142/s0192415x17500185
Royal Botanic Gardens, K., and Garden, M. B. (2021). World Flora Online. [Online]. Available: http://www.worldfloraonline.org/ (Accessed August 16, 2021).
Ryuk, J. A., Lixia, M., Cao, S., Ko, B. S., and Park, S. (2017). Efficacy and Safety of Gegen Qinlian Decoction for Normalizing Hyperglycemia in Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Complement. Ther. Med. 33, 6–13. doi:10.1016/j.ctim.2017.05.004
Sham, T. T., Chan, C. O., Wang, Y. H., Yang, J. M., Mok, D. K., and Chan, S. W. (2014). A Review on the Traditional Chinese Medicinal Herbs and Formulae with Hypolipidemic Effect. Biomed. Res. Int. 2014, 925302. doi:10.1155/2014/925302
Shi, H. X., and Li, Q. H. (2007). Research Progress of Traditional Chinese Medicine Treatment of Hyperlipidemia. J. Med. Forum 28 (10), 123–124.
Shi, M., Huang, F., Deng, C., Wang, Y., and Kai, G. (2019). Bioactivities, Biosynthesis and Biotechnological Production of Phenolic Acids in Salvia Miltiorrhiza. Crit. Rev. Food Sci. Nutr. 59 (6), 953–964. doi:10.1080/10408398.2018.1474170
Shi, Z. Q., Wang, L. Y., Zheng, J. Y., Xin, G. Z., and Chen, L. (2021). Lipidomics Characterization of the Mechanism of Cynomorium Songaricum Polysaccharide on Treating Type 2 Diabetes. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 1176, 122737. doi:10.1016/j.jchromb.2021.122737
Sil, R., and Chakraborti, A. S. (2016). Oxidative Inactivation of Liver Mitochondria in High Fructose Diet-Induced Metabolic Syndrome in Rats: Effect of Glycyrrhizin Treatment. Phytother. Res. 30 (9), 1503–1512. doi:10.1002/ptr.5654
Singh, S., Kushwaha, P., and Gupta, S. K. (2020). Exploring the Potential of Traditional Herbs in the Management of Diabetic Retinopathy: An Overview. Drug Res. (Stuttg) 70 (7), 298–309. doi:10.1055/a-1148-3950
Sirtori, C. R. (2014). The Pharmacology of Statins. Pharmacol. Res. 88, 3–11. doi:10.1016/j.phrs.2014.03.002
Soliman, A. M., Teoh, S. L., Ghafar, N. A., and Das, S. (2019). Molecular Concept of Diabetic Wound Healing: Effective Role of Herbal Remedies. Mini Rev. Med. Chem. 19 (5), 381–394. doi:10.2174/1389557518666181025155204
Song, M., Chen, L., Zhang, L., Li, C., Coffie, J. W., Fang, Z., et al. (2020). Cryptotanshinone Enhances Wound Healing in Type 2 Diabetes with Modulatory Effects on Inflammation, Angiogenesis and Extracellular Matrix Remodelling. Pharm. Biol. 58 (1), 845–853. doi:10.1080/13880209.2020.1803369
Song, T., Zhang, M., Wu, J., Chen, F., Wang, Y., Ma, Y., et al. (2020). Glioma Progression Is Suppressed by Naringenin and APO2L Combination Therapy via the Activation of Apoptosis In Vitro and In Vivo. Invest. New Drugs 38 (6), 1743–1754. doi:10.1007/s10637-020-00979-2
Su, K. H., Su, S. Y., Ko, C. Y., Cheng, Y. C., Huang, S. S., and Chao, J. (2021). Ethnopharmacological Survey of Traditional Chinese Medicine Pharmacy Prescriptions for Dysmenorrhea. Front. Pharmacol. 12, 746777. doi:10.3389/fphar.2021.746777
Subash-Babu, P., and Alshatwi, A. A. (2018). Ononitol Monohydrate Enhances PRDM16 & UCP-1 Expression, Mitochondrial Biogenesis and Insulin Sensitivity via STAT6 and LTB4R in Maturing Adipocytes. Biomed. Pharmacother. 99, 375–383. doi:10.1016/j.biopha.2018.01.084
Sui, Y., Liu, W., Tian, W., Li, X. Q., and Cao, W. (2019). A Branched Arabinoglucan from Angelica Sinensis Ameliorates Diabetic Renal Damage in Rats. Phytother. Res. 33 (3), 818–831. doi:10.1002/ptr.6275
Sun, C., Su, S., Zhu, Y., Guo, J., Guo, S., Qian, D., et al. (2020). Salvia Miltiorrhiza Stem-Leaf Active Components of Salvianolic Acids and Flavonoids Improved the Hemorheological Disorder and Vascular Endothelial Function on Microcirculation Dysfunction Rats. Phytother. Res. 34 (7), 1704–1720. doi:10.1002/ptr.6652
Sun, H. H., Chai, X. L., Li, H. L., Tian, J. Y., Jiang, K. X., Song, X. Z., et al. (2021). Fufang Xueshuantong Alleviates Diabetic Retinopathy by Activating the PPAR Signalling Pathway and Complement and Coagulation Cascades. J. Ethnopharmacol. 265, 113324. doi:10.1016/j.jep.2020.113324
Sun, J., Liu, Y., Yu, J., Wu, J., Gao, W., Ran, L., et al. (2019). APS Could Potentially Activate Hepatic Insulin Signaling in HFD-Induced IR Mice. J. Mol. Endocrinol. 63 (1), 77–91. doi:10.1530/jme-19-0035
Sun, N. Y., Liu, X. L., Gao, J., Wu, X. H., and Dou, B. (2021). Astragaloside-IV Modulates NGF-Induced Osteoblast Differentiation via the GSK3β/β-Catenin Signalling Pathway. Mol. Med. Rep. 23 (1), 19. doi:10.3892/mmr.2020.11657
Sun, R., Gu, J., Chang, X., Liu, F., Liang, Y., Yang, X., et al. (2021). Metabonomics Study on Orthotopic Transplantion Mice Model of Colon Cancer Treated with Astragalus Membranaceus-Curcuma Wenyujin in Different Proportions via UPLC-Q-TOF/MS. J. Pharm. Biomed. Anal. 193, 113708. doi:10.1016/j.jpba.2020.113708
Sun, S., Yang, S., An, N., Wang, G., Xu, Q., Liu, J., et al. (2019). Astragalus Polysaccharides Inhibits Cardiomyocyte Apoptosis during Diabetic Cardiomyopathy via the Endoplasmic Reticulum Stress Pathway. J. Ethnopharmacol. 238, 111857. doi:10.1016/j.jep.2019.111857
Sun, X., Li, S., Xu, L., Wang, H., Ma, Z., Fu, Q., et al. (2017). Paeoniflorin Ameliorates Cognitive Dysfunction via Regulating SOCS2/IRS-1 Pathway in Diabetic Rats. Physiol. Behav. 174, 162–169. doi:10.1016/j.physbeh.2017.03.020
Sun, Y. P., Zhang, T. J., Cao, H., Xu, J., Gong, S. X., Chen, C. Q., et al. (2015). Expression of Pungent-Taste Herbs and Their Applications in Clinical Compatibility. Chin. Traditional Herb. Drugs 46, 785–790. doi:10.7501/j.issn.0253-2670.2015.06.001
Taiwan Herbal Pharmacopeia 4th Edition Committee (2021). Taiwan Herbal Pharmacopeia 4th Edition. Department of Chinese Medicine and Pharmacy, Ministry of Health and Welfare.
Tang, Y., Zhong, Z. Y., Liu, Y. F., and Sheng, G. T. (2018). Obtusifolin Inhibits High Glucoseinduced Mitochondrial Apoptosis in Human Umbilical Vein Endothelial Cells. Mol. Med. Rep. 18 (3), 3011–3019. doi:10.3892/mmr.2018.9251
Testai, L., De Leo, M., Flori, L., Polini, B., Braca, A., Nieri, P., et al. (2021). Contribution of Irisin Pathway in Protective Effects of Mandarin Juice (Citrus Reticulata Blanco) on Metabolic Syndrome in Rats Fed with High Fat Diet. Phytother. Res. 35 (8), 4324–4333. doi:10.1002/ptr.7128
Thompson, P. D., Panza, G., Zaleski, A., and Taylor, B. (2016). Statin-Associated Side Effects. J. Am. Coll. Cardiol. 67 (20), 2395–2410. doi:10.1016/j.jacc.2016.02.071
Turkiewicz, I. P., Wojdyło, A., Tkacz, K., Nowicka, P., Golis, T., and Bąbelewski, P. (2020). ABTS On-Line Antioxidant, α-Amylase, α-Glucosidase, Pancreatic Lipase, Acetyl- and Butyrylcholinesterase Inhibition Activity of Chaenomeles Fruits Determined by Polyphenols and Other Chemical Compounds. Antioxidants (Basel) 9 (1), 60. doi:10.3390/antiox9010060
Wang, H., Shi, S., and Wang, S. (2018). Can Highly Cited Herbs in Ancient Traditional Chinese Medicine Formulas and Modern Publications Predict Therapeutic Targets for Diabetes Mellitus? J. Ethnopharmacol. 213, 101–110. doi:10.1016/j.jep.2017.10.032
Wang, K., Tang, Z., Zheng, Z., Cao, P., Shui, W., Li, Q., et al. (2016). Protective Effects of Angelica Sinensis Polysaccharide against Hyperglycemia and Liver Injury in Multiple Low-Dose Streptozotocin-Induced Type 2 Diabetic BALB/c Mice. Food Funct. 7 (12), 4889–4897. doi:10.1039/c6fo01196a
Wang, M., Zhao, H., Wen, X., Ho, C. T., and Li, S. (2021). Citrus Flavonoids and the Intestinal Barrier: Interactions and Effects. Compr. Rev. Food Sci. Food Saf. 20 (1), 225–251. doi:10.1111/1541-4337.12652
Wang, P., Fu, X. J., Zhou, Y., and Wang, Z. G. (2014). Effect of 5 Warm-Hot Nature Chinese Drugs for Promoting Blood Circulation and Removing Blood Stasis on 5-HT, NE, and Endocrine Hormones of Rats of Cold Coagulation and Blood Stasis Syndrome. Zhongguo Zhong Xi Yi Jie He Za Zhi 34 (11), 1365–1368.
Wang, Q., Zhou, J., Xiang, Z., Tong, Q., Pan, J., Wan, L., et al. (2019). Anti-diabetic and Renoprotective Effects of Cassiae Semen Extract in the Streptozotocin-Induced Diabetic Rats. J. Ethnopharmacol. 239, 111904. doi:10.1016/j.jep.2019.111904
Wang, S., and Qiu, X. J. (2019). The Efficacy of Xue Fu Zhu Yu Prescription for Hyperlipidemia: A Meta-Analysis of Randomized Controlled Trials. Complement. Ther. Med. 43, 218–226. doi:10.1016/j.ctim.2019.02.008
Wang, W., Xu, A. L., Li, Z. C., Li, Y., Xu, S. F., Sang, H. C., et al. (2020). Combination of Probiotics and Salvia Miltiorrhiza Polysaccharide Alleviates Hepatic Steatosis via Gut Microbiota Modulation and Insulin Resistance Improvement in High Fat-Induced NAFLD Mice. Diabetes Metab. J. 44 (2), 336–348. doi:10.4093/dmj.2019.0042
Wang, Y., Lin, D., Wang, X., Zhu, W., Ye, J., Li, G., et al. (2017). The Impact of a Novel Peach Gum-Derived Polysaccharide on Postprandial Blood Glucose Control in Streptozotocin-Induced Diabetic Mice. Int. J. Biol. Macromol. 98, 379–386. doi:10.1016/j.ijbiomac.2017.01.085
Wang, Z. J., Jin, D. N., Zhou, Y., Sang, X. Y., Zhu, Y. Y., He, Y. J., et al. (2021). Bioactivity Ingredients of Chaenomeles Speciosa against Microbes: Characterization by LC-MS and Activity Evaluation. J. Agric. Food Chem. 69 (16), 4686–4696. doi:10.1021/acs.jafc.1c00298
World Health Organization (2011). Global Status Report on Noncommunicable Diseases 2010. Geneva: World Health Organization.
World Health Organization (2021a). Noncommunicable Diseases Theme. [Online]. Available: https://www.who.int/data/gho/data/themes/noncommunicable-diseases (Accessed August 12, 2021).
World Health Organization (2021b). Noncommunicable Diseases: Risk Factors. [Online]. Available: https://www.who.int/data/gho/data/themes/topics/topic-details/GHO/ncd-risk-factors (Accessed August 12, 2021).
World Health Organization (2020). The Top 10 Causes of Death. [Online]. Available: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death (Accessed August 12, 2021).
World Health Organization (2021c). WHO Reveals Leading Causes of Death and Disability Worldwide: 2000-2019. [Online]. Available: https://www.who.int/news/item/09-12-2020-who-reveals-leading-causes-of-death-and-disability-worldwide-2000-2019 (Accessed August 31, 2021).
Wu, G. T., Liu, W. Z., Niu, T. H., Du, L. D., Wang, R. Q., Ren, Y., et al. (2016). Protective Effects of Angelica Sinensis Volatile Oil on Atherosclerosis in Hyperlipidemia Mice. Zhong Yao Cai 39 (9), 2102–2107.
Wu, L., Tang, Y., Shan, C., Chai, C., Zhou, Z., Shi, X., et al. (2018). A Comprehensive In Vitro and In Vivo Metabolism Study of Hydroxysafflor Yellow A. J. Mass Spectrom. 53 (2), 99–108. doi:10.1002/jms.4041
Xia, L. L., Zhu, Q. J., and Wu, Y. G. (2017). Hepatoprotective Effect of Peony Total Glucosides and the Underlying Mechanisms in Diabetic Rats. Pharm. Biol. 55 (1), 2178–2187. doi:10.1080/13880209.2017.1390589
Xie, X., Liu, M., and Meng, Q. (2019). Angelica Polysaccharide Promotes Proliferation and Osteoblast Differentiation of Mesenchymal Stem Cells by Regulation of Long Non-coding RNA H19: An Animal Study. Bone Jt. Res. 8 (7), 323–332. doi:10.1302/2046-3758.87.Bjr-2018-0223.R2
Xie, X., Zou, G., and Li, C. (2016). Purification, Characterization and In Vitro Antioxidant Activities of Polysaccharide from Chaenomeles Speciosa. Int. J. Biol. Macromol. 92, 702–707. doi:10.1016/j.ijbiomac.2016.07.086
Xiong, Z., Cao, X., Wen, Q., Chen, Z., Cheng, Z., Huang, X., et al. (2019). An Overview of the Bioactivity of Monacolin K / Lovastatin. Food Chem. Toxicol. 131, 110585. doi:10.1016/j.fct.2019.110585
Xu, X., Niu, L., Liu, Y., Pang, M., Lu, W., Xia, C., et al. (2020). Study on the Mechanism of Gegen Qinlian Decoction for Treating Type II Diabetes Mellitus by Integrating Network Pharmacology and Pharmacological Evaluation. J. Ethnopharmacol. 262, 113129. doi:10.1016/j.jep.2020.113129
Xu, Y., Lee, J., Park, Y. D., Yang, J. M., Zheng, J., and Zhang, Q. (2018). Molecular Dynamics Simulation Integrating the Inhibition Kinetics of Hydroxysafflor Yellow A on α-glucosidase. J. Biomol. Struct. Dyn. 36 (4), 830–840. doi:10.1080/07391102.2017.1300544
Yamashita, Y., Kishida, H., Nakagawa, K., Yoshioka, Y., and Ashida, H. (2019). Liquorice Flavonoid Oil Suppresses Hyperglycaemia Accompanied by Skeletal Muscle Myocellular GLUT4 Recruitment to the Plasma Membrane in KK-Ay Mice. Int. J. Food Sci. Nutr. 70 (3), 294–302. doi:10.1080/09637486.2018.1508425
Yang, A. L., and McNabb-Baltar, J. (2020). Hypertriglyceridemia and Acute Pancreatitis. Pancreatology 20 (5), 795–800. doi:10.1016/j.pan.2020.06.005
Yang, B., Ma, G., and Liu, Y. (2020). Z-ligustilide Ameliorates Diabetic Rat Retinal Dysfunction through Anti-apoptosis and an Antioxidation Pathway. Med. Sci. Monit. 26, e925087. doi:10.12659/msm.925087
Yang, D., Liu, T., Jiang, G., Hu, X., Zheng, T., Li, T., et al. (2020). Senkyunolide H Attenuates Osteoclastogenesis and Postmenopausal Osteoporosis by Regulating the NF-Κb, JNK and ERK Signaling Pathways. Biochem. Biophys. Res. Commun. 533 (3), 510–518. doi:10.1016/j.bbrc.2020.09.054
Yang, F., Lin, Z. W., Huang, T. Y., Chen, T. T., Cui, J., Li, M. Y., et al. (2019). Ligustilide, a Major Bioactive Component of Angelica Sinensis, Promotes Bone Formation via the GPR30/EGFR Pathway. Sci. Rep. 9 (1), 6991. doi:10.1038/s41598-019-43518-7
Yang, F., Qu, Q., Zhao, C., Liu, X., Yang, P., Li, Z., et al. (2020). Paecilomyces Cicadae-Fermented Radix Astragali Activates Podocyte Autophagy by Attenuating PI3K/AKT/mTOR Pathways to Protect against Diabetic Nephropathy in Mice. Biomed. Pharmacother. 129, 110479. doi:10.1016/j.biopha.2020.110479
Yang, L., Jiang, Y., Zhang, Z., Hou, J., Tian, S., and Liu, Y. (2020). The Anti-diabetic Activity of Licorice, a Widely Used Chinese Herb. J. Ethnopharmacol. 263, 113216. doi:10.1016/j.jep.2020.113216
Yang, M., Zhang, M., Liu, Q., Xu, T., Huang, T., Yao, D., et al. (2020). 18β-Glycyrrhetinic Acid Acts through Hepatocyte Nuclear Factor 4 Alpha to Modulate Lipid and Carbohydrate Metabolism. Pharmacol. Res. 157, 104840. doi:10.1016/j.phrs.2020.104840
Yang, W. J., Li, Y. R., Gao, H., Wu, X. Y., Wang, X. L., Wang, X. N., et al. (2018). Protective Effect of the Ethanol Extract from Ligusticum Chuanxiong Rhizome against Streptozotocin-Induced Diabetic Nephropathy in Mice. J. Ethnopharmacol. 227, 166–175. doi:10.1016/j.jep.2018.08.037
Ye, T., Meng, X., Wang, R., Zhang, C., He, S., Sun, G., et al. (2018). Gastrodin Alleviates Cognitive Dysfunction and Depressive-like Behaviors by Inhibiting ER Stress and NLRP3 Inflammasome Activation in Db/db Mice. Int. J. Mol. Sci. 19 (12), 3977. doi:10.3390/ijms19123977
Yin, X. J., and He, Q. Y. (2015). Compatibility Regularity of Compound Traditional Chinese Medicine Patents Based on Association Principle and Entropy Method. Zhongguo Zhong Yao Za Zhi 40 (3), 550–555.
Yin, Z., Wang, X., Yang, X., Chen, Y., Duan, Y., and Han, J. (2021). Salvia Miltiorrhiza in Anti-diabetic Angiopathy. Cmp 14, 960–974. doi:10.2174/1874467214999210111222918
You, L. Z., Lin, Y. X., Fang, Z. H., Shen, G. M., Zhao, J. D., and Wang, T. T. (2017). Research Advances on Astragaloside-IV in Treatment of Diabetes Mellitus and its Complications Pharmacological Effects. Zhongguo Zhong Yao Za Zhi 42 (24), 4700–4706. doi:10.19540/j.cnki.cjcmm.20171010.007
Yousof Ali, M., Zaib, S., Mizanur Rahman, M., Jannat, S., Iqbal, J., Kyu Park, S., et al. (2020). Poncirin, an Orally Active Flavonoid Exerts Antidiabetic Complications and Improves Glucose Uptake Activating PI3K/Akt Signaling Pathway in Insulin Resistant C2C12 Cells with Anti-glycation Capacities. Bioorg Chem. 102, 104061. doi:10.1016/j.bioorg.2020.104061
Yu, J. N., Cunningham, J. A., Thouin, S. R., Gurvich, T., and Liu, D. (2000). Hyperlipidemia. Prim. Care 27 (3), 541–v. doi:10.1016/s0095-4543(05)70164-0
Zhai, R., Jian, G., Chen, T., Xie, L., Xue, R., Gao, C., et al. (2019). Astragalus Membranaceus and Panax Notoginseng, the Novel Renoprotective Compound, Synergistically Protect against Podocyte Injury in Streptozotocin-Induced Diabetic Rats. J. Diabetes Res. 2019, 1602892. doi:10.1155/2019/1602892
Zhang, B., Zhang, X. L., Zhang, C. Y., Sun, G. B., and Sun, X. B. (2020). Effect of Guanxin Danshen Formulation on Diabetic Kidney Disease in Db/db Mice through Regulation of Nrf2 Pathway. Zhongguo Zhong Yao Za Zhi 45 (11), 2595–2600. doi:10.19540/j.cnki.cjcmm.20200418.401
Zhang, E., Yin, S., Song, X., Fan, L., and Hu, H. (2016). Glycycoumarin Inhibits Hepatocyte Lipoapoptosis through Activation of Autophagy and Inhibition of ER stress/GSK-3-Mediated Mitochondrial Pathway. Sci. Rep. 6, 38138. doi:10.1038/srep38138
Zhang, J., Cai, Z., Yang, M., Tong, L., and Zhang, Y. (2020). Inhibition of Tanshinone IIA on Renin Activity Protected against Osteoporosis in Diabetic Mice. Pharm. Biol. 58 (1), 219–224. doi:10.1080/13880209.2020.1738502
Zhang, J. Y., Cao, H., Gong, S. X., Xu, J., Han, Y. Q., Zhang, T. J., et al. (2016). Expression of Sweet-Taste of Chinese Materia Medica and its Application in Clinical Compatibility. Chin. Tradit. Med. Med. 47 (4), 533–539. doi:10.7501/j.issn.0253-2670.2016.04.001
Zhang, N., Zhao, S., Hong, J., Li, W., and Wang, X. (2019). Protective Effects of Kaempferol on D-Ribose-Induced Mesangial Cell Injury. Oxid. Med. Cell. Longev. 2019, 7564207. doi:10.1155/2019/7564207
Zhang, R., Qin, X., Zhang, T., Li, Q., Zhang, J., and Zhao, J. (2018). Astragalus Polysaccharide Improves Insulin Sensitivity via AMPK Activation in 3T3-L1 Adipocytes. Molecules 23 (10), 2711. doi:10.3390/molecules23102711
Zhang, R., Xing, B., Zhao, J., Zhang, X., Zhou, L., Yang, S., et al. (2020). Astragaloside IV Relieves Gestational Diabetes Mellitus in Genetic Mice through Reducing Hepatic Gluconeogenesis. Can. J. Physiol. Pharmacol. 98 (7), 466–472. doi:10.1139/cjpp-2019-0548
Zhang, R., Zhang, X., Xing, B., Zhao, J., Zhang, P., Shi, D., et al. (2019). Astragaloside IV Attenuates Gestational Diabetes Mellitus via Targeting NLRP3 Inflammasome in Genetic Mice. Reprod. Biol. Endocrinol. 17 (1), 77. doi:10.1186/s12958-019-0522-7
Zhang, T. J., and Liu, C.-X. (2015). Identification of Chinese Materia Medica and its Chemical Biology Characterization Path on Five Taste Theory. Chin. Traditional Herb. Drugs 46, 1–6. doi:10.7501/j.issn.0253-2670.2015.01.001
Zhang, W. N., Li, A. P., Qi, Y. S., Qin, X. M., and Li, Z. Y. (2018). Metabolomics Coupled with System Pharmacology Reveal the Protective Effect of Total Flavonoids of Astragali Radix against Adriamycin-Induced Rat Nephropathy Model. J. Pharm. Biomed. Anal. 158, 128–136. doi:10.1016/j.jpba.2018.05.045
Zhang, X., Li, L., Chen, T., Sun, Z., Tang, W., Wang, S., et al. (2018). Research Progress in the Effect of Traditional Chinese Medicine for Invigoration on Neurotransmitter Related Diseases. Evidence-Based Complementary Altern. Med. 2018, 1–14. doi:10.1155/2018/4642018
Zhang, Y., Gu, Y., Chen, Y., Huang, Z., Li, M., Jiang, W., et al. (2021). Dingxin Recipe IV Attenuates Atherosclerosis by Regulating Lipid Metabolism through LXR-Α/srebp1 Pathway and Modulating the Gut Microbiota in ApoE-/- Mice Fed with HFD. J. Ethnopharmacol. 266, 113436. doi:10.1016/j.jep.2020.113436
Zhang, Y., Tao, C., Xuan, C., Jiang, J., and Cao, W. (2020d). Transcriptomic Analysis Reveals the Protection of Astragaloside IV against Diabetic Nephropathy by Modulating Inflammation. Oxid. Med. Cell. Longev. 2020, 9542165. doi:10.1155/2020/9542165
Zhang, Y., Zhang, L., Zhang, Y., Xu, J. J., Sun, L. L., and Li, S. Z. (2016). The Protective Role of Liquiritin in High Fructose-Induced Myocardial Fibrosis via Inhibiting NF-Κb and MAPK Signaling Pathway. Biomed. Pharmacother. 84, 1337–1349. doi:10.1016/j.biopha.2016.10.036
Zhao, J., Yue, Y., Xie, Y., Liu, L., Cao, F., Gao, S., et al. (2017). Radix Cyathula Officinalis Kuan Inhibits Arterial Remodeling in Spontaneously Hypertensive Rats. Exp. Ther. Med. 14 (6), 5395–5400. doi:10.3892/etm.2017.5218
Zhao, W., Yuan, Y., Zhao, H., Han, Y., and Chen, X. (2019). Aqueous Extract of Salvia Miltiorrhiza Bunge-Radix Puerariae Herb Pair Ameliorates Diabetic Vascular Injury by Inhibiting Oxidative Stress in Streptozotocin-Induced Diabetic Rats. Food Chem. Toxicol. 129, 97–107. doi:10.1016/j.fct.2019.04.018
Zheng, J., Chen, M., Ye, C., Sun, X., Jiang, N., Zou, X., et al. (2020a). BuZangTongLuo Decoction Improved Hindlimb Ischemia by Activating Angiogenesis and Regulating Gut Microbiota in Diabetic Mice. J. Ethnopharmacol. 248, 112330. doi:10.1016/j.jep.2019.112330
Zheng, J., Guo, Y., Hu, B., Zhu, L., Yang, Y., Li, S., et al. (2020b). Serum Metabolomic Profiles Reveal the Impact of BuZangTongLuo Formula on Metabolic Pathways in Diabetic Mice with Hindlimb Ischemia. J. Ethnopharmacol. 258, 112928. doi:10.1016/j.jep.2020.112928
Zheng, X., Wang, H., Zhang, P., Gao, L., Yan, N., Li, P., et al. (2018). Chemical Composition, Antioxidant Activity and α-Glucosidase Inhibitory Activity of Chaenomeles Speciosa from Four Production Areas in China. Molecules 23 (10), 2518. doi:10.3390/molecules23102518
Zheng, X. W., Shan, C. S., Xu, Q. Q., Wang, Y., Shi, Y. H., Wang, Y., et al. (2018). Buyang Huanwu Decoction Targets SIRT1/VEGF Pathway to Promote Angiogenesis after Cerebral Ischemia/Reperfusion Injury. Front. Neurosci. 12, 911. doi:10.3389/fnins.2018.00911
Zhong, L. J., Xie, Z. S., Yang, H., Li, P., and Xu, X. J. (2017). Moutan Cortex and Paeoniae Radix Rubra Reverse High-Fat-Diet-Induced Metabolic Disorder and Restore Gut Microbiota Homeostasis. Chin. J. Nat. Med. 15 (3), 210–219. doi:10.1016/s1875-5364(17)30037-7
Zhou, D., Xie, L., Wang, Y., Wu, S., Liu, F., Zhang, S., et al. (2020). Clinical Efficacy of Tonic Traditional Chinese Medicine Injection on Acute Cerebral Infarction: A Bayesian Network Meta-Analysis. Evid. Based Complement. Altern. Med. 2020, 8318792. doi:10.1155/2020/8318792
Zhou, J., Zhang, L., Zheng, B., Zhang, L., Qin, Y., Zhang, X., et al. (2020). Salvia Miltiorrhiza Bunge Exerts Anti-oxidative Effects through Inhibiting KLF10 Expression in Vascular Smooth Muscle Cells Exposed to High Glucose. J. Ethnopharmacol. 262, 113208. doi:10.1016/j.jep.2020.113208
Zhou, Q., Chen, S., Li, H., Yang, B., Chen, T., Hu, T., et al. (2020). Tetramethylpyrazine Alleviates Iron Overload Damage in Vascular Endothelium via Upregulating DDAHII Expression. Toxicol Vitro 65, 104817. doi:10.1016/j.tiv.2020.104817
Zhou, X., Wang, L. L., Tang, W. J., and Tang, B. (2021). Astragaloside IV Inhibits Protein Tyrosine Phosphatase 1B and Improves Insulin Resistance in Insulin-Resistant HepG2 Cells and Triglyceride Accumulation in Oleic Acid (OA)-treated HepG2 Cells. J. Ethnopharmacol. 268, 113556. doi:10.1016/j.jep.2020.113556
Keywords: hyperlipidemia, hypolipidemic, traditional Chinese medicine, pharmacies, drug combination
Citation: Chi M-H, Chao J, Ko C-Y and Huang S-S (2022) An Ethnopharmaceutical Study on the Hypolipidemic Formulae in Taiwan Issued by Traditional Chinese Medicine Pharmacies. Front. Pharmacol. 13:900693. doi: 10.3389/fphar.2022.900693
Received: 21 March 2022; Accepted: 06 June 2022;
Published: 15 September 2022.
Edited by:
Hani Al-Salami, Curtin University, AustraliaReviewed by:
Huasheng Peng, China Academy of Chinese Medical Sciences, ChinaRolf Teschke, Hospital Hanau, Germany
Copyright © 2022 Chi, Chao, Ko and Huang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Shyh-Shyun Huang, c3NodWFuZ0BtYWlsLmNtdS5lZHUudHc=
†These authors have contributed equally to this work and share first authorship